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INTRODUCTION 
 Health is the ideal state of mankind. Without good heath we can 
hardly expect success in any walk of life. The dimensions of life-its 
length, its breadth and its depth are diminished when health gives way to 
disease. Health and disease are related by being at opposite extremes of 
the scale. Hence thinking positively about health will justify a person 
overlooking the dangers of disease. 
 Modern life beset with tensions and anxieties continues to crush 
the individuals with increasing number of diseases and the expected 
quality of life with harmony and peace seems to be far from reality. 
Medical science during the last century has kept abreast of civilization 
progress and continues in today’s jet age to make spectacular advances. 
Even though development in medicine have virtually wiped out many 
diseases, there are many diseases that are yet to be answered. Thus the 
frustrated people are moving towards the alternative system of medicine 
to find efficacious cure. 
 Siddha system of medicine which has survived through centuries, 
emphasize on positive health. Their medical education was a mysterious 
process of initiation and apprenticeship in the top, where there were two 
wings concentrating on studying the diseases and patients by methods of 
physical examination and intensive observation. The one we may call 
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scientists and the other, practitioners. The distinctive feature is the 
thoroughness with which the theoretical and scientific knowledge are 
fused with what experience teaches in the practical responsibility of 
taking care of human beings. 
 This ancient heritage, brilliant in conception, exhaustive in its 
systemization and precise in its technique of practice, strikes that 
dearrangement of 3 humors, 
¾ Vatham   
¾ Pitham           will produce disease. 
¾ Kabham 
 The disease ‘Udhira Vatha Suronitham’ is a chronic scourge 
which writes the obituary of joints and presents a nightmarish experience 
to the patients. Hence the author selected the disease for the present study 
with the trial medicines, to combat it successfully and keep it subdued 
and to improve the quality of the victims, afflicted by this malady. 
 This is a small effort on my part in this regard. I have just touched 
the fringe of several esoteric siddha medicines which would show the 
worth, value, rare insight and foresight of the siddhars. Further, study in 
this regard has to be continued in the course of time with the Almighty’s 
grace. 
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AIM AND OBJECTIVES 
The knowledge of preserving one’s health sound and thus 
prolonging life is said to have descended in this modern technological 
world.  The prolonged and uncertain course of   the disease   “UDHIRA 
VATHA SURONITHAM” calls for special emphasis and intended the 
author to bring an ideal treatment for the disease. 
Medicine, as everyone knows is not a mere science, but is an art as 
well. It is the only want of men with such knowledge of science and its 
practical practice with efficacious cures on hand. 
OBJECTIVES: 
¾ To collect various information about “UDHIRA VATHA 
SURONITHAM” and to expound the characteristics of 
aetiology, premonitory symptoms, homologatory signs and 
pathogenesis based on both siddha and modern aspects. 
¾ To access the prevalence of the disease with reference to age, 
sex, socioeconomic status, family history etc. 
¾ To correlate the etiology, classification, signs and symptoms 
of “Udhira Vatha Suronitham” in siddha aspect with 
Rheumatoid Arthritis in Modern science. 
¾ To propagate the views of siddhars, in terms of scientific  
proofs to the needy world. 
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¾ To highlight the siddha diagnostic principles in diagnosing the 
disease. 
¾ To evaluate the biochemical analysis, pharmacological 
analysis, acute toxicity study of trial medicine. 
¾ The study was designed to examine the effect of 
“KIRUBAGARA SHANMUGA CHENDURAM” given 
internally along with the external application of oil, 
“VATHATHIRKKU POOSA NOCHI ENNEI”. 
¾ The study also includes the use of modern diagnostic 
parameters in studying the progress of the patients.      
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ABSTRACT 
 The author has selected the disease “UDHIRA VATHA 
SURONITHAM” for the dissertation subject, because it presents a major 
challenge to the clinical judgement.  The chronicity, variability, tendency 
to exacerbate, unknown pathogenesis, variable response to specific 
treatment and myriad effects upon the patient’s life style, family 
relationship, self image and employability combine to complicate the 
therapeutic equation. 
 The inscriptions mentioned in the siddha literatures about this 
disease and therapeutics   impressed the author and made her to correlate 
the disease with “RHEUMATOID ARTHRITIS” as mentioned in 
modern medicine. 
 The diagnosis of disease was done by using siddha parameters like 
Mukkutra Verupadugal, Envagai Thervugal, Kaalam, Thinai and Modern 
Parameters. 20 In-Patients and 20 Out-Patients of both sexes were 
selected for the study and the trial drug, “KIRUBAGARA 
SHANMUGA CHENDURAM” was administered at a dose of 130mg 
with Chukku, Milagu, Omam Choornam and Murungaipattai Chaaru as 
vehicle which would effect a speedy recovery, (Ref: Pathartha Guna 
Vilakkam – Thathu Seeva Vaguppu Page No.55) with the external 
 
6
application of Oil, Vathathirkku Poosa Nochi Ennei (Ref: Vaithiya 
Thirattu, Page No.4) 
 The trial drugs were subjected to Biochemical and Pharmacological 
analysis.  Further Acute Toxicity study has been done to rule out any 
untoward effects. 
 After the administration of drug with dietic restrictions, majority of 
cases showed good clinical improvement with speedy recovery.  
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REVIEW OF LITERATURE 
SIDDHA ASPECTS 
 In siddha system of medicine, the physiological function in human 
system is mediated by three substances viz, Vatham, Pitham, Kabham. 
These three humors maintain the upkeep of the human body through their  
combined functioning. When deranged, they bring about diseases peculiar 
to their influence. In turn, they vitiate other structural and functional 
elements of living body known as Udal Thathus. 
VATHAM: 
 Vatham is the primal constituent of the living body whose structure 
is Vayu + Agayam. It maintains the cohesive unity of the body as a 
whole. It is unconditioned, absolute and all pervading in its nature and 
forms the life force of all human beings. 
 ‘nghw;wh kiuahd; Gidnka; auz;fhf;Fk; 
  nghw;wh kiuahd; Gfy;tnjd;  nghw;whk; 
  tstpdpNy ahf;Fuk;ig kd;ndd;d kd;d 
  tstpdpNy ahf;Fk; tsp.” 
                - Njiuah; akf ntz;gh. 
 Vatham is being hailed as the king, who rules the fort (Body) and 
enables the dwelling of the citizen (Uyir) in the fort.  Hence Theraiyar 
lauds Vatham as the prime force. 
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CHARACTERS OF VATHAM: 
¾ Hardness 
¾ Dryness 
¾ Lightness 
¾ Coldness 
¾ Mobility 
¾ Subtleness 
OPPOSITE QUALITIES OF VATHAM: 
¾ Softness 
¾ Unctuousness 
¾ Heaviness 
¾ Hotness 
¾ Stability 
¾ Solid 
DWELLING PLACES OF VATHAM: 
  ‘ehnkd;w thjj;Jf;F ,Ug;gplNk Nfsha; 
   ehgpf;Ff; fPnod;W etpy yhFk;.” 
  ‘mwpe;jpLk; thjk; mlq;F kyj;jpdpy.;” 
  ‘nespe;jpl;lthjk ghdj;ij gw;wp 
   epiwe;jpiliar; Nrh;e;Je;jpf;Ff; fPNo epd;W 
   Fsph;e;jpl;l %yj;J}nlOe;J fhk 
   Nfhbapiliag; gw;wpnaOq;Fzj;ijg;ghNu.” 
- Neha; ehly; Neha; Kjy; ehly;> ghfk; -!I. 
 Abaanan, Idakalai, Undhiyin keel Moolam, Pelvis, Bones, 
Muscles, Nerves, Ear, Joints, Skin, Hairfollicles, Stools. 
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FUNCTIONS: 
 ‘xOq;Fld; jhJ Vo; %r;Nrhq;fp  ,aq;f 
  vOr;rpngw vg;gzpAkhw;w - vOe;jphpa 
  Ntfk; Gyd;fSf;F Nktr; RWRWg;G 
  thfspf;Fk; khe;jh;f;F thA.” 
! ! ! ! ! - kUj;Jtj; jdpg;ghly; 
¾ Giving briskness 
¾ Respiration 
¾ Maintenance of body and mind in a balanced state 
¾ Regulation of reflexes (14 urges) 
¾ Enhancement of functioning of seven Udal Thathukkal 
¾ Protection and strengthening of sense organs. 
DISTURBANCE IN VATHAM: 
¾ Body ache 
¾ Pricking pain 
¾ Nerve weakness 
¾ Shivering 
¾ Numbness in feet 
¾ Joint pain 
¾ Cramps in calf muscles 
¾ Increased thirst 
¾ Weakness of organs 
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¾ Breaking pain in the knee joints 
¾ Pain in the leg and thigh 
¾ Unable to do flexion and extension of the limbs 
¾ Pilo-erection 
¾ Dryness 
¾ Polydypsia 
¾ Excess salivation 
¾ Anuria and constipation 
¾ Astringent taste perception in all food 
¾ Darkness of skin, eyes and urine. 
TYPES OF VATHAM: 
 Vatham is not mere wind, but also that which causes motion, 
energy and sensation of every cell in the body. It is further divided into 
ten types. 
i)  PRAANAN:  
 Lies in the chest. It regulates respiration and digestion. 
ii) ABAANAN:   
   This is responsible for expulsion of faeces, urine, sperm, ova and 
also menstrual outflow. It also spreads the nutrients of the digested food 
all over the body for its utilization. 
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iii) VIYAANAN: 
  It pervades all over the body. It controls voluntary and involuntary 
movements, sensory perception. It distributes the energy of the 
assimilated food to various parts of the body. 
iv) UDHAANAN: 
Regulates speech. It induces the physiological reflexes such as 
vomiting, hiccough, cough, sneezing etc. 
v) SAMAANAN:  
 It controls digestion. Acts as activating factor for the other vayus. 
vi) NAAGAN:   
It is responsible for the intelligence quotient of an individual, 
opening and closure of eyelids. 
Vii) KOORMAN:  
It is responsible for yawning, closure of eyelids, lacrimal secretion 
and vision. 
vii) KIRUKARAN:  
It resides in tongue and is responsible for salivary secretion, nasal 
secretion, hunger, sneeze, cough etc. 
viii) DEVATHATHAN: 
  It causes fatigue, angry and ocular movements. 
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ix) DHANANJEYAN:  
 It causes bloating of the body after death and escapes after third 
day of death. 
VATHAM & SUVAIGAL: 
 Siddha system explains about six types of tastes, which are formed 
by the combination of two boothams.  They are sweet, salt, sour, bitter, 
pungent and astringent.  Some tastes will aggravate vatham and some 
tastes will neutralize vatham.  Further if the thodam (vatham) is 
increased, it will cause an alteration of taste in tongue, which is 
appreciable by the patient.  So suvaigal holds a separate place in 
diagnosing. 
 ‘khj;jpa Gspg;G kPwpy; te;jpLk; thjkhFk;” 
!!!!!!!!!!!!!!!!- mfj;jpa ehb. 
‘thjNk Gspg;G Ntz;Lk; td;gpj;jk; frg;G Ntz;Lk;” 
                - ,uj;d RUf;f ehb. 
‘GspJth; tpQ;Rq;fwp ahw;G+hpf; Fk;thjk;” 
The above versions denotes that  sour, astringent and pungent  
tastes hold its part in raising vatham. 
 ‘thjk; Nkypl;lhy; kJuk; Gsp cg;G” 
!!!!!!!!!!!!!!!.!fz;Zrhkpak;.!!
Exaggerated vatham can be neutralized by tastes like sweet, sour 
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and salt.  The basic concept behind this is, among the panchabootham, 
Vin and Vayu forms vatham.  So tastes formed by other boothams are 
advisable to neutralize it.  It is noted that, in the formation of sweet, sour 
and salt tastes vayu and vin doesn’t takes part. 
VATHA DISEASES: 
  ‘thjkyhJ Nkdp nflhJ” 
 - Njiuah;. 
‘MdNjhh; thj ehb ,lh;e;Jw tYtha; epw;fpy; 
 Cdkh Klypy; Neha;fSyhtpNa epw;Fk;.”  
‘thjNk fjpj;jNghJ thAT nkOk;Gq; fz;Bh; 
 thjNk fjpj;jNghJ thAT te;jpLQ; rd;dp Njh\k; 
 thjNk fjpj;jNghJ te;jpLk; tpahjp NkYk; 
 thjNk fjpj;jNghJ ty;Yly; nkype;J nfhy;Yk.;” 
    - rpfpr;rh uj;d jPgk;.  
Which depicts that derangement of humor vatham, will produce 
many hazardous symptoms in bringing down the normal healthy 
condition of the body.  
 Yugi Munivar, classified Vatha diseases into 80 types, while 
naming them he mentioned 85 types. 
 ‘vd;dNt thjkJ vz;gjhFk; 
  Vw;wkhk; NgUila ntopiyf; Nfsha;” 
    - ghly; 246. 
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AETIOLOGY: 
 The various causative factors for vatha diseases are summarized 
below. 
ACCORDING TO YUGI VAIDHYA CINTHAMANI: 
 ‘vd;dNt thje;jh ndz;gjhFk; 
   ,fj;jpNy kdpjh;fSf; nfa;AkhW 
   gpd;dNt nghd;djidNa NrhuQ;nra;J 
   ngupNahu;fs; gpuhkziuj; J}ldpj;Jk; 
  td;d Njtr; nrhj;jpy; NrhuQ;nra;J 
   khjhgpjh FUit kwe;j Ngu;f;Fk; 
  fd;dNt Ntjj;ij epe;ij nra;jhy; 
   fhaj;jpw; fye;jpLNk thje;jhNd.” 
      - ghly; 243. 
Frittering away gold, blaspheming elders, holymen and Vedas, 
obsession of temple property, obliviousness of parents, teachers and god 
all leads to vatha diseases. ! ! !  
‘jhndd;w frg;NghL Jth;g; Giwg;G 
   rhjfkha; kpQ;RfpYk; rikj;j tz;zk; 
  Mndd;w thwpdJ Grpj;j yhYk; 
   Mfhaj; J}wyJ Fbj;jyhYk; 
  ghndd;w gfYwf;f kpuhtpopg;G 
   gl;bdpNa kpfTWjy; ghu nka;jy; 
  Njndd;w nkhopahh; Nkw;rpe;ijahjy; 
   rPf;fpukha; thjkJ nrdpf;Fe; jhNd.”!
- A+fp itj;jpa rpe;jhkzp> ghly; - 244. 
Increased intake of food rich in bitter, astringent and pungent taste, 
intake of stale food, drinking rainwater, day time sleep and awakening at 
night, undue starving, lifting heavy objects and increased sexual passion 
will produce vatha diseases. 
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‘gfuNt thjkJ Nfhgpj; jg;Ngh 
 gz;ghf ngz;Nghf kJjhd; nra;apy; 
 efuNt ntFJ}utop elf;fpy; 
 espuhd fhw;WNk gdpNkw;gl;lhy; 
 kpfuNt fha;fs; fdpfpoq;F jd;id 
 kpftUe;jp kPwpNa japh;jhd; nfhz;lhy; 
 KfuNt KJnfYk;ig KWf;fp nehe;J 
 Koq;fhYk; fizf;fhYk; fLg;G cz;lhNk.” 
- A+fp itj;jpa rpe;jhkzp> ghly; - 285. 
During vitiation of vatham, indulgence in sexual act, walking for 
long distance, exposure to dampness and cold, increased intake of fruits, 
vegetables, curd will affect vertebral joints, knee joint and ankle joint. 
ACCORDING TO PARARASA SEKARAM: 
 ‘njhopy; ngWifg;Gf; fhh;j;jy;> Jth;j;jy; tpQ;fpDQ; NrhWk; 
  gioajhk; tuF kw;wiwg; ige;jpid aUe;jp dhYk; 
  vopy; ngwg; gfYwq;fp ,utpdp Ywq;fh jjhYk; 
  kioepfh; FoypdhNy thjq; Nfhgpf;Fq; fhNz.” 
- ghly; 232. 
¾ Intake of food with excessive bitter and astringent taste 
¾ Intake of stale food 
¾ Daytime sleep and awakening at night will produce Vatha diseases. 
‘fhzNt kpfTz;lhYk; fUJgl;bdp tpl;lhYk; 
 khdid ahh;fz; Nkhfkwf;fpD kpFe;jp;l;lhYk; 
 Mzt kyq;f lk;ik aq;qNd tplhj jhYk; 
 thDjd; kley ;yhNs thjq; Nfhgpf;Fk; fhNz.” 
  - ghly; 233. 
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Excessive intake of food, starvation, increased sexual passion, 
anger, greed plays a vital role in the causation of vatha diseases. 
 ‘ghupdpw; gag;gl; lhYk; gyUld; Nfhgpj; jhYk; 
  fhnudf; fUfp Nahbf; fOkuj; Juj;jp dhYk; 
  Vh;ngW jdJ neQ;rpd; kpfj;Jf;f kile;jpl; lhYk; 
  ghhpa fhw;wp dhSk; glhpDk; thjq; fhZk;.” 
- ghly; 234. 
Fear, anger, excessive running, stress, exposure to wind produces 
vatha diseases. 
 ‘fhyq;fz;khwp Az;Zq; fhhpaj; jhYe;jz;zPh; 
  rhyNt aUe;jp dhYQ; re;jpap Yl;fhh;e; jhYk; 
  Nfhykhk; Gspg;G nea;iaf; Fiwtw tUe;jp dhYk; 
  thythh; Kiyey; yhNs thjKw; gtpf;Fq; fhNz.” 
- ghly; vz; 235. 
Irregular food habits, increased intake of food rich in sour taste, 
ghee will bring out vatha diseases. 
thjNeha;fspd; ,ay;G: (characteristics of vatha diseases) 
 ‘fhzg;gh thjkPwpy; fhy;iffs; ngUj;J NehTk; 
  G+zg;gh Fly; Gul;Lk; kyryk; nghUkpf;  fl;Lk; 
  Czg;gh FspUq; fha;r;ry; clk;ngy;yhk; Fj;J tha;T 
     tPzg;gh FjkpWf;Fk; tpah;itAk; Nth;f;Fk; jhNd.”! !
!            - mfj;jpah; itj;jpa fhtpak; 1500. 
‘Nktpa thjQ; nra;Ak; Fze;jid tpsk;gf; Nfsha; 
 jhtpNa tapW ke;jQ; re;Jfs; nghUe;J NehthQ; 
 rPtpa jhJ ehrQ; nrWj;Jld; rpWePh; tPOq; 
 fhtpaq; fz;zpdhNs kykJ fUfp tPOk;”. 
- mfj;jpah; MAs; Ntjk;. 
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‘thjj;jpd; FzNk njd;dpy; tapwJ nghUkpf; nfhs;Sk; 
 jhJfSyh;e;J if fhy; re;Jf;fs; fLg;G Njhd;We; 
 jPjw;Wr; rpWePh; jhDQ; rpWj;Jld; fLj;J tPOk; 
 NghJw;w thjnkd;W Gfd;wdh; Kdpth; jhNk”. 
      - mfj;jpah; MAs; Ntjk;. 
‘vwpa ey;thj nkwpf;Fq; Fzq;NfS 
 Fwpnad iffhy; Fisr;R tpyhr;re;J 
 gwpnad nehe;Jlw; gr;irg; Gz;zhFNk 
 Gz;zha; typf;Fk; ngUFk; FlNyhbj; 
 jz;zh kyj;ijj; jk;gpf;Fk; Nghf;fhJ 
 xz;zhd Mrdk;  cwNt ruf;fpLk; 
 gz;zhh; Fsph;rPjk; gUj;jpLk; thjNk”. 
      - jpU%yh; itj;jparhuk;. 
         ‘re;jputhj Klk;G Fsph;e; njOe;Nj eLf;FQ; rPjtha; thk; 
 Ke;jpa Fj;jprpte;J re;Jfs; NjhWq; File;J nkhspfs; tPq;Fk; 
 Te;jpa njhe;j thjk; euk;Gfnsy;yh kprpe;J tyk; tPlhJ 
 Me;J mt;thF thjk; tPf;fKz;lh Klypw;wp kpUz;lhNk.” 
- Njiuah; thflk;. 
 
‘thjk; te;Jw;w NghJ tapwJ nghUkp nfhs;Sk; 
 jhjtpo;e;jpLg;G iffhy; re;Jfs; fLg;Gj; Njhd;Wk; 
 rPnjhU kyK ePUe; rpWj;jJld; fLj;J tpo 
 khjtkiu Nky; te;j thjj;jpd; FzkpjhNk.” 
      - A+fp Kdpth; ngUE}y; itj;jpa fhtpak; 1000. 
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From the above poetic versions, it is clear that the major characters 
of vatha diseases are joint pain, swelling, difficulty in walking, 
constipation, burning micturation, oliguria, dyspnoea, flatulence, fever, 
fatigue, giddiness, nerve weakness etc. 
EXAGGERATED VATHAM: 
Increase in vatham produces, 
¾ Body pain 
¾ Joint pain 
¾ Astringent taste perception in all food 
¾ Dark coloured stools and urine 
¾ Difficulty in movement 
¾ Constipation 
¾ Distress 
¾ Fatigue 
DECLINED VATHAM: 
Decrease in vatham produces, 
¾ Body pain 
¾ Low pitched voice 
¾ Exhaustion 
¾ Low intelligent quotience 
¾ Giddiness 
¾ Syncope 
¾ Symptoms of increased Kabham. 
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UDHIRA VATHA SURONITHAM 
 “Udhira Vatha Suronitham” is one among the 80 types of vatha 
diseases explained by yugi munivar. 
 The term ‘Udhiram’ and ‘Suronitham’ are synonyms and 
indicates blood. The main pathology lies in the blood indicating it as an 
autoimmune disease. 
 “Udhira Vatha Suronitham”, a condition that affects joints, with 
symptoms of pain and swelling in smaller joints, anorexia and fatigue. 
CLINICAL FEATURES OF “UDHIRA VATHA SURONITHAM”: 
In Yugi vaidhya cinathamani, 
 ‘itfpjkha;f; fizf;fhY Koq;fhy; jhD 
     kw;flQ; re;JGw tbAk; tPq;fpr; 
  nra;fpjkhQ; rpWtpuy;fs; kpfTk; nehe;J 
   rpe;ijjL khwpNa rypg;Gz; lhFk; 
  igfpjkhk; gapj;jpaj;jpy; thj kpQ;rpg; 
  ghukh Aw;gtpj;J moYz; lhFk; 
  ca;fpjkhk; mrdkJ jhDk; Ntz;lh 
   cjputhjr; RNuhzpjj;jp Dzh;r;;rpahNk.” 
      - ghly; 319. 
The above poetic version depicts the following clinical features, 
¾ Swelling of ankle and knee joints 
¾ Swelling of the hind foot 
¾ Pain in minor joints of hand and feet 
¾ Confused state of mind 
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¾ Fatigue 
¾ Increased production of heat in the body than that is produced in 
paithiya vatham 
¾ Anorexia 
In Pararasa Segaram, 
 ‘nrhw;rpj Tjpu thj RNuhzpj Koq;fhy; jhDk; 
  nghw;fizf; fhYQ; re;Jk; Gwtb jhDk; tPq;fp 
    ew;fZ tpuy;f nzhe;J eLg;gapj ;jpath jj;jpy;  
  cw;gtf; FzK Kz;lh KWE}ypw; nrhd;d jhNk.” 
 - ghly; 278. 
¾ Swelling of ankle and knee joints 
¾ Swelling of hind foot 
¾ Pain in the interphalangeal joints 
¾ Characters of paithya vatham are seen. 
PATHOLOGY: 
 ‘gpzpapDw; gj;jpia NgRtd; gpzpKjy; 
  thjgpj; jq;fg kd; ke;jphp je;jphp 
  tPjkh Alyuz; nka;k;Gu tuR nra; 
  Kiw nrAkhjyhd;.” 
- Njiuah; fhg;gpak;.  
(thjk; - murd;> gpj;jk; - ke;jphp> fgk; - Nrdhjpgjp) 
Which highlights that the main factor in the causation of disease  
are vatham, pitham and kabham. 
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 Vatham is the prime force that impacts movement to every living 
cell in the body.  Its dwelling place lies in the bones, muscles, nerves, 
joints etc.  Hence it is responsible for the movement of parts involved in 
locomotor system.  When this Uyir Thathu, Vatham is affected the other 
two, Pitham and Kabham gets dearranged and in turn, they vitiate the 
other structural and functional elements of living body called Seven Udal 
Thathus. 
1. Viyaanan which is responsible for the voluntary and 
involuntary movements and nutrition of the tissue gets affected 
leading to restriction of movements and lassitude. 
2. Samaanan which neutralizes other vitiated vayus gets 
affected.Further it is needed for normal digestion.So 
dearrangement of this vayu produces loss of appetite and 
indigestion. 
3. Involvement of Abaana Vayu also plays a main role in the 
manifestation of signs and symptoms.  Abaanan which is 
responsible for distribution and assimilation of nutritional 
factors gets affected leading to symptoms like constipation. 
 The main function of Pitham which represents Agni is 
Thermogenesis or heat production, metabolism within its limits, process 
of digestion etc.  Its vitiation produces inflammatory changes in joints.  
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Among the five types of Pitham, the following four types gets affected in 
Udhira Vatha Suronitham. 
1. Ranjaga Pitham which gives colour to blood.  
2. Saathaga Pitham which is needed to carry out normal activities 
gets affected.   
3. In few, Anal Pitham which is needed for digestion and  
4. Prasaga Pitham which gives complexion to skin gets affected 
leading to anorexia and pallor of skin respectively. 
 The detoriation of the two main kuttram also accompany the Kabha 
kutram whose structure is Earth + Water and is concerned with the 
maintenance of Smooth working of joints, Integration of structural 
elements of the body into stable structures etc.  Hence detoriation of 
kabham which is of five types affects the following.   
1. Santhiga Kabham which is needed for normal maintenance of 
synovial fluid gets affected.   
2.  Avalambagam which forms the basis for all other four types of 
Kabham gets affected.  
3. In few, Kilethagam gets affected leading to loss of appetite. 
Thus disturbance in Mukkutram produces, 
¾ Pain, swelling of joints, joint stiffness, restriction of movements 
due to Vatham. 
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¾ Inflammatory changes in joints like redness, warmth due to 
Pitham. 
¾ Erosion of bony margin, osteoporotic changes, increase in the 
Synovial fluid are due to disturbed Kabham. 
Disturbances in Vatham, Pitham and Kabham gets reflected on Udal 
Thathus leading to change in normalcy of body either conferring a pre 
disposition to or actually causing disease.  The Seven Udal Thathus that 
supports the body in their state of equilibrium are as follows. 
1. Saaram  -  Strengthens the body and mind. 
2. Senneer  -  Gives power, knowledge and boldness to the  
mankind. 
3. Oon  -  It gives structure and shape to the body and is  
responsible for movements of the body. 
4. Kozhuppu  -  It lubricates the joints and organs and facilitates  
their functions. 
5. Enbu  -  It protects all the internal organs and forms   
structural framework of the body. 
6. Moolai  -  Resides inside the core of bones.  It  strengthens  
and maintains the normal condition of bones. 
7. Sukkilam/ -  Meant for reproduction (Male and Female   
   Suronitham     respectively). 
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In Uthira Vatha Suronitham, the affected Udal Thathus are, 
 Saaram -  Loss of appetite, lassitude. 
 Senneer -  Decrease in Udal Vanmai (Anaemia, presence  
  of  RA  Factor). 
 Oon   -  Muscle wasting, swelling. 
 Kozhuppu -  Emaciation, restriction of joint movements. 
 Enbu  -  Swelling of joints and deformity of joints. 
NAADI PATHOLOGY: 
 ‘jpUj;jkhk; thjj; NjhNl jPq;nfhL gpj;jQ;Nrupy; 
  nghUe;Jfs; NjhWk; nehe;J”. 
- Fzthflk; Nehapd; rhuk;. 
‘fhzg;gh thjkPwpy; 
 fhy;iffs; nghUe;jp NehFk;.” 
- fhtpa ehb. 
Vitiation of Vatham and Pitham produces joint pain. 
‘thjj;jpd; FzNk jd;dpy; 
 tapwJ nghUkpf; nfhs;Sk; 
 jhjj;jpy; Nkdp iffhy; 
 re;JNk fLg;G Njhd;Wk.;” 
- Fwpailahs ehb. 
Increase in Vatham results in abdominal distension and pain in the joints. 
‘mwpe;Jghh; thjNk jdpj;jjhdhy; 
 md;dk; Nghy; elf;Fkg;gh ehbghU 
 rupe;jplNt fhy;Klf;Fk; NghJ fhl;Lk;” 
- mfj;jpah; uj;jpdr; RUf;fk;. 
 
25
Vitiated Vatham causes difficulty in walking and impaired  
functioning of lower extremities. 
 ‘mwpAk;; thjj;jpy; mLj;j gpj;jkhapd;  
  FwpaJjhd; thAk; FoWk; newpahy; 
  FspUq; fhy;tPq;Fk; Fly;Gwl;Lk; tpk;kpj; 
  njsptpy;iy Gj;jpnadr; nrg;G” 
!!!!!!!!!!!!!!!!!!!!!!- fz;Zrhkpak; vd;Dk; itj;jpa Nrfuk</!
DIFFERENTIAL DIAGNOSIS: 
 Yugi Munivar in his “Yugi Vaidhya Cinthamani”, mentioned about 
80 types of Vatha diseases.  Among them, the following diseases have 
joint pain as main clinical feature. 
¾ Oorusthamba Vatham 
¾ Malaithakamba Vatham 
¾ Santhu Vatham 
¾ Paithya Vatha Suronitham 
¾ Vatha Suronitham 
1. CU];jk;g thjk; (Oorusthamba Vatham): 
‘Mnkd;w thjkJ cs;s lq;fp 
 mbj;Jiljhd; Fwq;fpuz;L kstha;g; gw;wpf; 
 fhnkd;w iffhypy; tpuYQ; Rw;wpf; 
 fdj;JNk rhzpaJ nghjpe;jhw; Nghyj; 
 Njnkd;w rpue;jdpNy ghu Kz;lha;j; 
 Njfnkq;F %jpNa jpkpUz;lhFk; 
 ehnkd;w elf;nfhzh nthLf;f khfp 
 eypA+Uj; jk;gkJ eZFq; fhNz.” 
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Pain in both the thighs, swelling of fingers and toes, numbness, 
generalized oedema of the body and inability to walk are the symptoms of 
this disease. 
2. kiyj;jfk;g thjk< (Malaitha Kamba Vatham) 
‘Fk;gkhq; ifapd;kzpf; fl;L jd;dpw; 
 Ftpe;jiuapy; nkhj;ijNgh Yuj;Jf; fhZe; 
 Jk;gkh kq;fq;fs; Jbg;g jhFe; 
 Jtz;LNk fhy; ifA eLf;f khFk; 
 mk;gkh kiuf;Ff;fPo; jpkpUz; lhFk; 
 mjuNk kpff;fWj;J ntbg;Gz; lhFk; 
 tk;gkhk; thAe;jhd; gupA ehw;wk; 
 tUkiyj;j fk;gj;jpd; khh;f;fkhNk.” 
 Congestion of wrist joint, twitching, tremors in upper, lower 
extremities, numbness below the hip joint, black – fissured lips and 
passing off foul flatus will be seen. 
3. re;Jthjk; (Santhu Vatham) 
‘nra;ifjhd; re;JfS kpfj; jpkpu;e;J  
 rlnkq;F nehe;JNk kpft ow;wp 
 ieifaha; eYj;JNk kapu;f; $r;rypl;L 
 ehzpNa Kd;Nghy; eil nfhlhJ 
 ikifjhd; kaf;fnkhL tha;ePUWk; 
 tuz;bLNk ehTjh dbf;f bf;Ff; 
 iffhy;jhd; juzpjdpw; wupf; nfhzhJ 
 rQ;rupf;FQ; re;Jthk; thjq; NfNs.” 
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 Pain in joints, body pain, pilo erection, inability to walk, giddiness, 
dryness of tongue, excessive salivation and unable to keep the limbs in 
floor are the features of this disease. 
4. gapj;jpa thj RNuhzpjk< (Paithya Vatha Suronitham) 
‘czu;r;rpaha;r; RNuhzpje;jhd; kpfnt Jk;gp 
 Cf;fkha;j; Njfnkq;F kpfNt nehe;J 
 Kzu;r;rpaha; Koq;fhy;fs; Koq;if nahf;f 
 Kidahd rpWtpuy;fs; fd;dk; new;wp 
 jzu;r;rpaha;r; re;JrU thq;f nkq;Fk; 
 jhl;bf kha;f;File;J RuK Kz;lhk; 
 gzu;r;rpaha; ghz;lJNghy; Nkdp ahFk; 
 gapj;jpa thjRNuhzpjj;jpd; gz;GjhNd.” 
 Generalised body pain, severe pain in the knee joint, elbow joint, 
minor joints, temporomandibular joint and all other joints, fever and 
anaemia are the features of this disease. 
5. thj RNuhzpjk< (Vatha Suronitham) 
‘mwpe;jpl;l tq;fnkyh nkypTkhfp 
 mirthd jt;tplq;fs; tPf;fkhfp 
 ewpe;jpl;l eilnfhlh jhdp Uj;jy; 
 eypahfp nkhop nkhopa tPf;fkhfr; 
 nrwpe;jpl;L Njfnkq;F kirT fhzy; 
  Nrhw;wpd;Nk dpidtpd;wpj; J}f;fkhjy; 
 mwpe;jpl;l thajdp dPh;jh D}wy; 
 thjRNuh zpje;jhDk; tFj;jthNw.” 
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 Emaciation, swelling in movable joints, inability to walk, tremors, 
anorexia, increased sleep and excessive salivation are the features of this 
disease. 
PINIYARI MURAIMAI: 
 Piniyari Muraimai is the diagnostic modalities followed in siddha 
system of medicine and is based on, 
¾ Poriyal Arithal 
¾ Pulanal Arithal 
¾ Vinathal 
 Poriyal Arithal and Pulanal Arithal goes hand in hand with the 
concept of examining the patients ‘Pori’ and ‘Pulan’ with that of the 
physician’s ‘Pori’ and ‘Pulan’.  Vinathal is the method of enquiring about 
the details of the patient’s complaints in their own words or from their 
attendants.  This helps to elicit an accurate account of the symptoms that 
represents the clinical problems. 
 Envagai Thervugal, though it is mentioned in a single phrase, the 
actual boundary is unknown, each entity dealing with a vast subject.  It 
spreads its eagle’s eye view and also a thorough check up in each and 
every thing. 
  ‘njhLf;fYw;w ml;ltpjg; gupl;ir jd;id 
   Jyf;fKWk; gz;bjNu njsp tjhfg; 
   gFf;fupa ehbNa eP gpbj;Jg; ghU 
   gfh;fpd;w thh;j;ij ghh; ehitg; ghU 
   tFf;fhpa Njfnkdj; njhl;Lg; ghU 
   rfpf;fhpa kyj;ijg; ghh; ryj;ijg; ghU 
   rhu;e;j tpopjidg; ghh;j;J njsptha; fhNz.” 
! ! ! ! ! ! - mfj;jpah; itj;jpa ty;yhjp 600. 
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 It constitutes Naadi, Sparisam, Naa, Niram, Mozhi, Vizhi, Malam, 
Moothiram. 
1. Naadi (Pulse): 
The science of pulse forms a very important branch in the siddha 
system of medicine and it enables a physician to diagnose and suggest 
forth with remedies there for.  The pulse-waves as felt on the radial 
artery, one inch from the wrist by means of palpation with the tip of 
index, middle and ring finger corresponds to Vatham, Pitham and 
Kabham.  They exist in the ratio of 1:1/2:1/4 normally.  Derangement of 
this ratio leads to various disease entities. 
 In Udhira Vatha Suronitham, Vatha Pitha Naadi, Pitha Vatha Naadi 
is commonly seen.  
2. Sparisam (Skin): 
Skin examination can be made by inspection and palpation.  It  
reveals about the warmth/chillness, dry/weeping skin, rough/smooth, 
soft/hard, tenderness, presence of ulcers, fissures, swelling, wrinkles, 
hair, pigmentation etc. 
 In Udhira Vatha Suronitham, the affected part feels warm with 
redness, swelling and tenderness. 
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3. Naa (Tongue): 
The colour, character and condition of tongue changes according to  
changes in mukkutram. 
 In Udhira Vatha Suronitham, few cases had coated tongue. In few 
cases who were anaemic the tongue was pale. 
4. Niram (Colour): 
Signs of different complexions in Vatham, Pitham, Kabham and 
Thontha thegis, cyanosis, pallor, yellowish discolouration can be studied 
by means of niram. 
 In Udhira Vatha Suronitham, the patient is of mixed complexion 
and the affected parts gets swollen with hyperaemia. 
5. Mozhi (Speech): 
It constitutes high, low pitched voice, slurring and incoherent  
speech, nasal speech, hoarseness of voice etc. 
 In Udhira Vatha Suronitham, the speech is normal. 
6. Vizhi (Eye): 
Both motor and sensory disturbance of eye are noticed. Changes  
according to mukkutram, redness of eyes, ulcers, paleness, excessive 
lacrimation, swelling, sunken eyes, corneal ulcers, other diseased 
conditions should be noted. 
 In Udhira Vatha Suronitham, if the patient is anaemic, pallor of 
conjunctiva will be seen. 
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7. Malam (Stools): 
1. Vatha type :  Black coloured stools with constipation. 
2. Pitha type :  Loose stools with yellowish red colour. 
3. Kabha type :  White coloured stools with mucus. 
4. Thontha type :  Stools possess some of the features of  
    two thodams. 
In Udhira Vatha Suronitham, constipation is noted in few patients. 
8. Moothiram (Urine): 
It includes Neerkuri and Neikuri. 
Neerkuri: 
¾ Niram -  Indicates the colour of urine voided. 
¾ Manan -  Indicates the smell of urine voided. 
¾ Edai -  Indicates the specific gravity of urine voided. 
¾ Nurai -  Indicates the frothy nature of urine voided. 
¾ Enjal -  Indicates the quantity of urine voided. 
 In addition, the frequency of micturation and sedimentations are 
noted. 
 In Udhira Vatha Suronitham, no abnormalities are seen in the 
above features. 
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Neikuri: 
 ‘mUe;J khwpujKk; mtpNuhjkjha; 
  m0fy; myu;jy; mfhyCz; jtpu;e;jow; 
  Fw;wstUe;jp cwq;fp itfiw 
  Mbf; fyrj; jhtpNa fhJ nga; 
  njhU K$u;j;jf; fiyf;Fl;gL ePupd; 
  epwf;Fwp nea;f;Fwp epUkpj;jy; flNd.” 
      - Njiuah; 
Prior to the day of urine examination, the patient was advised to  
take a balanced diet and the quantity of food must be proportionate to his 
appetite and he should have a good sleep. 
 After waking up in the morning, urine that is voided first is 
collected in a glass container and is subjected to analysis within one hour. 
 A drop of gingelly oil is added without disturbance and neikuri is 
noted in direct sunlight. 
Character of Vatha Neer: 
‘muntd ePz;bd0Nj thjk;.” 
 When the drop of oil lengthens like a snake, it indicates ‘Vatha 
Neer’. 
Character of Pitha Neer: 
‘MopNghy; gutpd; m0Nj gpj;jk;.” 
 When the oil drop spreads like a ring, it indicates ‘Pitha Neer’. 
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Character of Kabha Neer: 
‘Kj;njhj;J epw;fpd; nkhoptnjd; fgNk.” 
 When the oil drop remains that of pearl, it indicates ‘Kabha Neer’. 
Character of Thontha Neer: 
  ‘mutpyhopAk; Mopapy; muTk; 
   mutpd;Kj;Jk; Mopapy; Kj;Jk; 
   Njhw;wpy; njhe;j Njhlq;fshNk.” 
 Thontha neer appears as the combination of  above patterns. 
Character of Mukkutra Neer: 
 When the oil drop gets immersed in urine, it indicates ‘Mukkutra 
Neer’. 
 In ‘Udhira Vatha Suronitham’, the Neikuri appears to be thontha 
neer indicating patterns of aravil aazhi and aazhiyil aravu. Few cases 
showed patterns that of the snake indicating vatha neer.  
 Besides Envagai Thervugal, ‘Thinai’ and ‘Paruva Kaalangal’ also 
plays a main role in the diagnosis of disease. 
Thinai (Land and Place) 
 The geographical distribution of land is classified into the five 
groups. 
 1. Kurinji  -  Mountain and its surroundings 
 2. Mullai  -  Forest and its adjacent areas 
 3. Marutham -  Field and its surroundings 
 4. Neithal  -  Sea and its surroundings 
 5. Paalai  -  Desert and its surroundings. 
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 Each region has its own characters, which influences the 
inhabitants, physical, mental, economical and occupational activities.  In 
each region, some ailments are endemic based on the climatic features of 
that area. 
‘Udhira Vatha Suronitham’ is common in Marutha Nilam and 
Neithal.  Even though marutha nilam is suitable land for living and to be 
free from diseases, modification in lifestyle and food habits brings about 
the disease. 
PARUVA KAALANGAL: 
 The seasonal variation mainly depends upon the temperature, 
humidity, air and other climatic factors. 
 There are six main seasons which constitute Perum pozhuthu. 
Perum pozhuthu Months Vatham Pitham Kabham
Kaar kaalam Avani, Puratasi    
Koothir kaalam Iyppasi, Kaarthigai D   
Munpani Kaalam Markazhi, Thai  D  
Pinpani kaalam Maasi, Panguni    
Elavaenir kaalam Chithirai, Vaigasi    
Mudhuvaenir kaalam Aani, Aadi   D 
 D  - Normal State 
 - Alteration from normal state 
 - Aggravation and spread to other humors 
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 According to climatic condition that prevails in every season, 
changes will occur in the human beings which will modify the 
physiological state and makes them susceptible to certain specific disease 
likely to occur in that season.   
 Thus Vatham gets provoked from its normal state in its own 
location during “Muthuvaenir Kaalam”.  This altered vatham spreads to 
other location in “Kaar Kaalam”.  Altered Vatham subsides in “Koothir 
Kaalam”.  The above three conditions are named as Thannilai Valarchi, 
Vetrunilai Valarchi and Thannilai Adaithal. 
 The incidence of “Udhira Vatha Suronitham” is more in Koothir 
Kaalam and Munpani Kaalam.  
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PINI NEEKAM: 
The main aim of Pini Neekam is based on the following objectives. 
¾ Accurate diagnosis is essential for the early application of 
appropriate forms of therapy. 
¾ To bring the three thodams to equilibrium. 
¾ Treatment of the disease and its symptoms by internal 
medicines, topical application of medicated oil (Thokkanam), 
fomentation (Otradam) in affected region. 
¾ Education of patient in maintaining the joint stability by means 
of Yogasanas. 
¾ Allowing only such food and drink as would further hasten the 
recovery. 
Pinineekam includes Kaappu, Neekkam and Niraivu. 
1. KAAPPU (Prevention): 
“The curse causeless shall not come” is a proverb.  Knowing the cause 
there by removing it and thus preventing the disease is the main aim of 
siddha system of medicine.  Thiruvalluvar depicted,  
‘kUe;njd Ntz;lhthk; ahf;iff;F mUe;jpaJ 
 mw;wJ Nghw;wp cz;zpd.;” 
This Kural highlights that no medicine is required by the body if 
food is taken on complete digestion on what was taken before.  Thus   
change in food habits plays a main role in the causation of diseases. 
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Further, following of Theraiyar Pini Anugaa Vidhi will help in the 
prevention of diseases.  The main highlights of Theraiyar Pini Anugaa 
Vidhi are as follows. 
 “Twice per day we take our meals 
  Thrice we never take 
  At night we sleep but never in day 
  Once a month we take to sex 
  Water we drink at meals alone 
  However thirsty, not other time 
  Except yam, roots we wont 
  Never we take plaintain matured  
  Tender ones we take and walk 
  Lovely after taking meals.” 
 “Twice a year emetic we take 
   Thrice the purge we never forget 
   Sniff we have eight times a year 
   Weakly shave we never forget 
   Every fourth day we bath with oil 
   Collyrium twice a week we take 
   What has death to do with us.” 
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2. NEEKKAM (Treatment): 
 ! ‘tpNurdj;jhy; thjk; jhOk; 
   tkdj;jhy; gpj;jk; jhOk; 
   erpa mQ;rdj;jhy; fgk; jhOk;.” 
 Vatha diseases can be brought down by ‘Viraesanam’.  For this 
laxatives and purgatives are given according to patient’s tolerance to 
drug.  All the patients were given ‘AGASTHIYAR KULAMBU’ at a 
dose of 130mg with Inji Surasam (Boiled juice extract from Ginger) on 
the first day in the early morning.  They were put in diet allowing only to 
take butter milk. 
  ‘Ntu;ghU jioghU kpQ;rpdf;fhy; 
   nky;y nky;yg; gw;gr; nre;J}uk; ghNu.” 
! Even though there are times of remission in many cases, Uthira 
Vatha Suronitham tends to run a progressive course.  In an early stage 
itself, destruction of joint tissue takes place and a later chronic stage leads 
to deformity.  This intended the author to select the trial medicine in 
preventing the amount of damage which occurs during the first stage and 
later restoring the lost functions.  The trial drug was given from the next 
day of Viraesanam.  
PATHIYAM: 
 “Take anything you like” – siddha system does not believe in this 
dictim.  The system of arranging dietary with certain restrictions in diet 
and physical activities is Pathiyam.  This hastens the speedy recovery of 
the frustrated people. 
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Nrh;g;gd: 
 ‘nrq;fOePu ;Nfhl;le; Njd;kpsF ey;nyz;nza; 
   jq;FngUq; fhae; jOjhio - vq;nfq;Fk; 
   $l;LrpW Kj;Jnea; Nfhjpy; cSe;jpitfs; 
   thl;Lkzp yj;ij kjp.” 
- gjhh;j;j Fz rpe;jhkzp. 
nrq;fOePh; fpoq;F> ngUq;fhak;> Nfh\;lk;> jOjhio> FwpQ;rp 
Njd;> rpw;whkzf;F nea;> kpsF> cSe;J> vs; nea; Kjypatw;iw 
Nrh;f;f Ntz;Lk;.   
ePf;f Ntz;bad:  
‘fLF ew;wpyj;njz;nza; $o;g; ghz;lq;fs; fliy 
   tLtjhfpa njq;Fkh tUf;if ew;fhak; 
   kbtpyhj nts;Ss;sp nfhs; Gifapiy kJngz; 
   ,lJ ghfNyhL fj;jhp ePf;fp tpr;rh gj;jpaNk.” 
Riu> G+riz> nts;sup> Gliy> gPH;f;F> nkhr;ir> fhuhkzp> 
nfhs;S> fLF> Njq;fha;> fpoq;F tiffs;> ke;jKs;s gjhu;j;jk;> 
Gifapiy> kJ> ngz;Nghfk; Kjypatw;iw ePf;f Ntz;Lk;.!  
THOKKANAM, OTRADAM: 
 Almost everyone, regardless of age, values the ability to function 
as independently as possible during everyday life.  The ultimate goal is 
the achievement of an optimal level of symptom-free movement during 
basic to complex physical activities. 
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 Thokkanam is topical application of medicated oil.  It is the 
systematic and scientific manipulation of body tissues, best perfomed by 
hands.  Ottradam is fomentation and is done with the use of herbs etc. 
 Both of which produces pain relief and increases the blood flow 
owing to arteriolar and capillary dilatation and reduces joint stiffness. 
 They increase the extensibility of collagen tissues so that 
contractures can be stretched. 
YOGA: 
 Yogasanas are specialized postures of the body and helps in the 
development of an inner awareness and results in deep relaxion and 
energy conservation.  Prescription of these asanas which is synchronized 
with breathing helps in the correction of impairment there by improving 
the musculo-skeletal function and maintaining the state of well being. 
Udhira Vatha Suronitham patients were adviced to perform 
¾ Savasanam, two times daily for a session of 10 minutes. 
Sava – dead body.  Should lie motionless on the floor in supine  
posture like dead body with a view to secure complete relaxation of all 
parts of the body and removing stress. 
¾ Deep relaxation techniques once daily for a period of 20 
minutes. 
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When the acute symptoms subsides the following Aasanas are 
advised to protect the diseased joints against further damaging, stress and 
in preserving joint motion and preventing  joint stiffness and deformity.  
¾ Sukhasana (Comfortable posture) 
¾ Padmasana (Lotus posture) 
¾ Ardha Padmasana (Half lotus posture) 
¾ Utkatasana (Half squat posture) 
¾ Vrikshasana (Tree posture) 
¾ Bhadrasana (Beneficial posture) 
¾ Vajrasana (Adamant posture) 
¾ Makarasana (Crocodile posture) 
Further the patients were adviced to do Pranayamam in association  
with Mudras. 
¾ Naadi Sudhi (Using Nasika Mudra) 
¾ Abdominal Breathing (Using Cin Mudra) 
¾ Thoracic Breathing (Using Cinmaya Mudra) 
¾ Clavicular Breathing (Using Adi Mudra) 
¾ Full Yogic Breathing (Using Brahma Mudra) 
Practice of this pranayama relieves stress, tension, anxiety and  
insomnia there by bringing stability to mind. The Mudras preserves the 
joint movements of fingers. 
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3. NIRAIVU (Life style modification): 
 Self help techniques were advised to keep inflammatory process at 
a minimum, there by preserving joint motion. 
SELF MANAGEMENT TECHNIQUES: 
¾ Rest - reduces the general activities there by avoiding straining 
of joints and to conserve the quota of vitality.   
¾ Positive mental attitude. 
¾ Use of joint – Patient is told, the value of correct posture and 
methods of using the joints wisely to reduce stress on the 
painful joints. 
¾ Assistive devices – Like splints, walking sticks provides 
strength and reduces pain and inflammation. 
¾ Adequate sleep. 
¾ Relaxation techniques. 
¾ Modification in daily activities like avoiding walking on hard 
and uneven surfaces, avoiding squatting on ground, etc.  
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MODERN ASPECTS 
Articulations or Joints are specialized anatomical structures at 
which the ends of certain bones are joined or the borders of other bones 
are juxtaposed.  These osseous junctions are secured by ligaments, 
fibrous capsule and other binding tissues which restrict movements or 
permit varying degrees of movements.  Joints vary widely in their 
structure, frequently presenting unique morphological features, adapted to 
specific functional requirements.  
JOINT CLASSIFICATION: 
 Depending on the morphological characteristics of the joints, they 
are classified into, 
1. Fibrous Joints   -  Many of which are immovable and are  
united by fibrous tissue (synarthroses). 
2. Cartilaginous Joints  -  Slightly movable, the union between  
the bones occurs via cartilage 
(amphiarthroses). 
3.  Synovial Joints  -  Freely movable (diarthroses). 
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SYNOVIAL JOINTS: 
 Synovial Joints are highly evolved articulations which permit free 
movements. Because the human lower limbs are concerned with 
locomotion and the upper limbs provide a great versatility of movements, 
it is not surprising that most of the joints are of the synovial type.  The 
integrity of a synovial joint results from its ligaments and capsule which 
bind the articulation externally and to some extent from the surrounding 
muscles.  The contiguous bony surfaces are covered with hyaline 
cartilage and the joint cavity is surrounded by a fibrous capsule, the inner 
surface of which is lined by a synovial layer containing cells that are 
thought to secrete the viscous lubricating synovial fluid.  
STRUCTURES: 
1. Articular Cartilage: Firmly adherent to the articular surfaces of  
majority of bones.  They are neither innervated nor supplied with 
blood vessels. 
2. Ligaments: are composed mainly of bundles of collagenous fibres.  
They are pliant and flexible to allow perfect freedom of movement.   
3. Articular Capsule: Forms a complete envelope for a freely 
movable joint and consists of external fibrous layer and internal 
synovial layer.  The fibrous layer gets attached to the periosteum 
along the entire circumferance of the articular end of each bone.  
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Its flexibility permits movements, yet its strength protects joint 
from dislocation. 
4. Synovial Membrane: Covers the inner surface of the fibrous 
capsule, forming a closed sac called the synovial cavity.  It is 
composed of loose connective tissue and it has a free surface of 
finger like projection called the Synovial Villi.  The synovial cavity 
contains only enough synovial fluid to moisten and lubricate the 
synovial surfaces, but in an injured or inflammed joint, the fluid 
may accumulate in painful amounts.  
PHYSIOLOGY OF JOINTS: 
 As joint is a very well engineered structure, frictionless motion is 
provided by the combination of a smooth articular cartilage as well as 
lubrication of both the articular cartilage and the synovial membrane 
together which make up the entire surface area of the inside of the joints.  
Shock absorption to the joint is provided by the combination of 
structures, including articular cartilage, subchondral bone and soft tissue 
structures (Joint Capsule and Ligaments).  Because of its re-silent nature 
and ability to compress, articular cartilage in itself is a good shock 
absorber but its thickness and overall volume is far less than bone or soft 
tissues.  Hence the soft tissues and bones are the primary shock absorbers 
in joint and any disease that affect bones or soft tissue is going to 
interfere with this shock absorption.  Re-silence of the soft tissue is 
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important for normal motion as well as shock absorption.  Hyaluronic 
acid provides lubrication to the synovial membrane surface in addition to 
another protein structure called Lubricin and is involved in the lubrication 
of articular cartilage.  The substance moving over the surface of joints is 
called Boundary Lubrication.  A second mechanism of lubrication of 
cartilage is effected by fluid being squeezed out of the cartilage on to the 
surface when weight bearing occurs. 
CLASSIFICATION OF JOINT DISEASES 
(Ref – Natarajan’s Text book of Orthopaedics and Traumatology) 
I. Infective Arthritis 
(Bacterial, Viral, parasite) 
 
Acute infection            Chronic infection 
 
Acute pyogenic arthritis  
Acute gonococcal arthritis     Non Specific  Specific  Parasitic infection 
Acute rheumatic arthritis   
Small pox arthritis          Pyogenic   Tubercular arthritis Guinea worm 
     arthritis     Syphilitic arthritis     arthritis 
             Gonococcal arthritis  
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II. Rheumatoid Arthropathy 
 
Rheumatoid arthritis    Seronegative – spondylo arthropathy 
 1. Rheumatoid Arthritis   1. Ankylosing spondylitis 
 2. Juvenile Rheumatoid   2. Reiter’s disease 
       Arthritis (J.R.A)    3. Psoriatic arthritis 
       4. Enteropathic arthritis 
       Primary osteoarthritis 
III Degenerative Arthrosis        
       Secondary osteoarthritis  
       Tabes - Charcot’s arthropathy 
       Syringo myelia 
IV Neuropathic Arthropathy   Leprosy 
       Diabetes mellitus 
Gout 
V Metabolic Arthritis    Pseudo Gout 
       Alkaptanuric Arthritis        Reactive arthritis 
VI Arthritis in systemic disorder   
Haemophilic arthritis 
       Villo-nodular synovitis 
VII Miscellaneous Joints 
       Synovial chondromatosis 
VII Hysterical joint 
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RHEUMATOID ARTHRITIS 
 Rheumatoid arthritis embrace an amazing array of hereditary and 
acquired disorder with a wide variety of clinical features.  Rheumatoid 
arthritis is a disease of unknown cause, and the current thinking is that an 
interplay between genes, infectious agent contributes to initiate an 
autoimmune disease mechanism that results in inflammation, dominantly 
at limb joints, often with destructive features.  The term rheumatoid 
arthritis was first used by sir Archibald Garrod to describe a chronic non-
suppurative inflammatory arthropathy (Rheuma - flux,                          
eidos - resemblance), a condition resembling rheumatism. 
 We are all familiar with the saying regarding rheumatic fever, “it 
licks the joints but bites the heart.” Contrarily it can be said of rheumatoid 
arthritis, “it bites the joints, licks all other systems of the body and barks 
at the treating physician.” 
DEFINITION: 
 Rheumatoid arthritis is a highly inflammatory polyarthritis often 
leading to joint destruction, deformity and loss of function.  Additive, 
symmetric swelling of peripheral joints is the hallmark of the disease.  
Extra-articular features and systemic symptoms can commonly occur and 
may antedate the onset of joint symptoms.  Chronic pain, disability and 
excess mortality are unfortunate sequelae. 
 
 
49
FREQUENCY: 
 The world wide incidence of RA is approximately 3 cases per 
10,000 population and the prevalence rate is approximately 1%.  First 
degree relatives of patients with RA have an increased frequency of 
disease (2-3 %).  Disease concordance in monozygotic twins is 
approximately 15-20% suggesting that non-genetic factors play an 
important role.  Because world wide frequency is relatively constant, a 
ubiquitous infectious agent has been postulated to play an etiologic role.  
SEX: 
 Females are 2-3 times more likely to develop RA than males. 
AGE: 
 The frequency of RA increases with age and peaks in persons aged 
35-50 years.  Nevertheless, the disease is observed in both elderly persons 
and children. 
AETIOLOGY: 
 The cause of rheumatoid arthritis is unknown.  Genetic, 
environment, immunologic, and infectious factors may play significant 
roles.  Socioeconomic, psychological and lifestyle factors may influence 
disease outcome. 
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1. Genetic: 
Approximately 60% of patients with RA carry the so called  
shared epitope of the HLA-DR4 cluster, which constitutes one of the 
peptide binding sites of certain HLA-DR molecules associated with RA. 
In addition, HLA-DR1 also carries this shared epitope and confers risk in 
certain areas. 
2. Environmental: 
For many decades, numerous infectious agents have been 
suggested to induce RA.  Among these are Mycoplasma organisms, 
Ebstein-Barr and Rubella viruses and others. 
This supposition is further supported indirectly by the following: 
¾ Occasional reports of flulike disorders preceding the start of 
arthritis. 
¾ The inducibility of arthritis in experimental animals with 
different bacteria or bacterial products (eg, streptococcal cell 
walls) 
¾ The presence of bacterial products including bacterial RNA in 
patient joints. 
¾ The activity of several agents that have antimicrobial effects as 
disease-modifying drugs (e.g.  antimalarials).  
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3. Immunologic: 
All of the major immunologic elements play a fundamental role  
in the initiation, propagation and maintenance of the autimmune process 
of RA. The exact orchestration of the cellular and cytokine events that 
lead to pathologic consequences, such as synovial proliferation and 
subsequent joint destruction, is complex.  It involves T and B 
Lymphocytes, antigen-presenting cells (e.g. B cells, macrophages, 
dendritic cells) and numerous cytokines.  Aberrant production and 
regulation of both pro and anti-inflammatory cytokines and cytokine 
pathways are found in RA. 
T cells are assumed to play a pivotal role in the initiation of RA 
and the key player in this respect is assumed to be the Th1 CD4 cells.  
 These cells may subsequently activate macrophages and other cell 
populations, including synovial fibroblasts.  The latter 2 populations are 
the main producers of the proinflammatory cytokines TNF-alpha and IL-1 
that appears to be the major driving forces of inflammation. 
 B cells are important in the pathologic process because they may 
serve as antigen-presenting cells and activated T cells produce numerous 
autoantibodies (e.g. RF, Citrullinated proteins) and secrete cytokines.  
 Experimental models suggest that synovial macrophages and 
fibroblasts may become autonomous and thus lose responsiveness to       
T-cell activities in the course of the disease. 
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IMMUNOPATHOLOGY:   
The pathological hallmark of RA is synovial membrane 
proliferation outgrowth associated with erosion of articular cartilage and 
subchondral bone.  In early stages, the most obvious histological changes 
are confined to the synovial microvasculature which shows evidence of 
endothelial damage, infilteration by polymorpho nuclear leucocytes and 
obliteration by thrombus.  In chronic phase, polymorpho nuclear 
leucocytes are less obvious but the synovium is infilterated by large 
number of inflammatory cells (macrophages, T&B lymphocytes, 
dendritic cells, plasma cells).  The plasma cells in the subsynovium 
synthesize large quantities of immunoglobulin, much of which is IgM and 
IgG rheumatoid factor.  They have the ability to form immune complexes 
that can activate complement and is important in either initiating or 
prolonging local inflammation within the joint.  Antigen-Antibody 
complexes formed within the joint cavity can become trapped in hyaline 
cartilage and fibrocartilage, where they cause changes in matrix macro 
molecules.  Ultimate destruction of cartilage, bone, tendons and ligaments 
probably results from proteolytic enzymes, metallo proteinases.  
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CLINICAL FEATURES: 
 Patients often present with constitutional complaints including 
malaise, fever, fatigue, weight loss and myalgias.  Most patients with the 
disease have an insidious onset.  It may begin with systemic features, 
such as fever, malaise, arthralgias and weakness, before the appearance of 
joint inflammation and swelling.   
JOINT FEATURES: 
RA is typically a distal, symmetrical, small joint polyarthritis 
involving proximal interphalangeal and metacarpophalangeal joints of the 
hands, wrist, metatarsophalangeal joints, ankles, knees and cervical spine.  
The shoulders, elbows and hips are less frequently involved, but can be a 
major source of morbidity.  Any synovial joint in the body may be 
affected.  In addition periarticular synovial structures such as bursae and 
tendon sheaths are commonly inflammed. 
 Most common symptoms described by patients are pain and 
pronounced stiffness.  The later frequently exhibits a diurnal rhythm, 
worse on rising in the morning and then recurring towards the evening, 
Perhaps reflecting the diurnal variation in plasma cortisol levels.  The 
affected joints are frequently tender, swollen and warm and there may be 
limitation of both active and passive movements.  Progressive destruction 
of the articular cartilage, subchondral bone and periarticular soft tissues 
eventually combine to produce the characteristic deformities seen in long 
standing RA. 
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UPPER LIMBS: 
1. Hands and wrists:  
Early in the disease there may be soft tissue swelling around  the 
affected joints.  Involvement of the proximal interphalangeal joints gives 
a spindle shaped appearance to the fingers and soft tissue swelling can be 
observed over the ulnar styloid and in the 2nd and 3rd 
metacarpophalangeal joints (MCP).  Tenosynovitis of the long flexor 
tendons in the palm of the hand may exacerbate stiffness of the fingers 
and cause “Trigger finger”.  Similar synovitis of the wrist within the 
flexor retinaculam may cause compression of the median nerve with the 
typical features of Carpal Tunnel Syndrome. Persistent synovitis with 
erosion of the articular surfaces, weakening of the joint capsules and 
muscle weakness, with or without tendon rupture will inevitably lead to 
deformities. 
i) Volar subluxation of fingers at the MCP Joints: 
Occurs as a result of destruction of the articular cartilage and 
subsequent instability of these joints. 
ii) Ulnar deviation and subluxation of the fingers: 
Occurs as a result of instability of the MetaCarpophalangeal joints.  
The fingers may tend to drift in an ulnar direction because of the ulnar 
vector of the action of both flexor and extensor finger tendons. 
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iii) Swan Neck deformity: 
Develops from hyper extension of the proximal  
interphalangeal joints in conjunction with flexion of distal 
interphalangeal joints with subsequent contracture of the intrinsic 
muscles which become extensors rather than flexors of the 
proximal interphalangeal joints. 
iv) Boutonniere (Button-Hole) deformity: 
Results from flexion contractures of proximal  
interphalangeal joints associated with hyper extension of distal 
interphalangeal joints.  A similar process at the carpometacarpal  
joint of  the  thumb may  give  rise  to  the   Z-thumb deformity. 
v) Piano-Key sign: 
Can be detected when weakening of the distal radio  ulnar 
ligament by synovitis allows the distal ulna to migrate dorsally so 
that it overrides the radius.  The ulna can be depressed by pressure 
like a piano key. 
vi) Carpal collapse and fusion: 
May occur late in the disease when instability of the wrist 
may lead to collapse of the carpal bones, causing foreshortening of 
the carpal and ultimately, spontaneous fusion of the wrist. 
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2. Elbows and Shoulders: 
Involvement of the elbows is less common than of the wrist  but 
severe destruction may occur, leading to pronounced deformity and 
disability.  There may be inflammation of the subacromial bursae or 
supraspinatous tendon in addition to glenohumeral joint synovitis, 
producing a typical painful arc syndrome.  
LOWER LIMBS: 
1. Feet and Ankles: 
Active synovitis of the metatarso phalangeal joints leads to 
spreading of fore foot.  Subluxation of metatarsal heads into the soles 
results in cockup and valgus deformities causing painful walking and 
difficulty with foot wear.  Pain arises in the ball of foot (metatarsalgia).  
Which vary in intensity from walking on pebbles to like walking on 
broken glass.  Valgus deformity of the hind foot is usual and 
excacerbated by rupture of the tibialis posterior tendon.                                                       
2. Knee :             
      Involvement of knee is an important cause of disability from an  
early stage of disease. Synovial proliferation is usually most obvious in 
the supra patella pouch and there may be pronounced wasting of the 
quadriceps as a result of reflex muscle inhibition.  Synovial effusion 
typically produces posterior knee pain in the early stages by stretching the 
posterior capsule of the joint.  This may lead to the development of a 
popliteal cyst (Baker’s cyst).  Valgus deformity of the knee are usual 
consequence of loading. 
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3. Hip: 
Involvement of hip is uncommon.  Pain is usually present in  the 
groin, buttock and abduction of hip are reduced ultimately  leading to 
fixed flexion deformity of the joint. 
AXIAL SKELETON: 
 Spinal involvement is limited to upper cervical articulation.  
Neckpain and stiffness are common and leads to erosion of bones and 
ligaments in cervical spine.  Vertebral arteries may also be compressed 
resulting in vertebro basilar insufficiency with vertigo or syncope 
especially on downward gaze.  The risk of cord compression is greatest in 
those with a subluxation exceeding 8mm and there is also vertical 
subluxation of the atlanto axial joint.  Instability of atlanto axial joint 
results from erosion of the Odontoid peg or rupture of supporting 
ligaments. Symptoms suggestive of atlanto axial disease includes high 
cervical pain radiating to the occiput and temporal regions, exacerbated 
by neck movements.  Brisk tendon jerk, positive Hoffman sign, upgoing 
plantar response, loss of proprioception, vibration sense indicates damage 
to posterior column.  
OTHER JOINTS: 
 Hoarseness of the voice may occasionally be caused by effusion 
within the cricoarytenoid joints.  Temporomandibular joint disease causes 
pain on chewing and restricts opening of mouth. 
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2. Extraarticular Features: 
 These tend to be more numerous and severe in those with high 
titres of rheumatoid factor in blood. Three major pathological phenomena 
dominate the disease.  
1. Inflammation of membranes 
2. Nodule formation 
3. Vasculitis. 
i) Rheumatoid  Nodules: 
 Subcutaneous and intracutaneous nodules are the hall mark of the 
disease in ¼ th of patients.  They are firm, non-tender swellings that 
occur on the extensor surface of the fore arm and olecranon sites, where 
repeated minor trauma could initiate their formation.  They may also 
develop in many other tissues including eye (Scleromalacia), pleura, 
pericardium, parenchyma of lungs and heart. 
ii) Haematological manifestation: 
1. Anaemia: 
Moderate normochromic normocytic anaemia is a finding in  active 
RA.  Factors that are related to the inflammatory process probably 
contribute to this anaemia.  There may be ineffective erythropoiesis and 
red blood cell survival is reduced.  Iron  binding capacity is typically 
reduced in active rheumatoid arthritis. 
2. Thrombocytosis, Leukopenia is a finding in patients with Felty’s 
Syndrome.  
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iii) Vasculitis: 
 Intimal hyperplasia of the small terminal digital vessels causes very 
limited cutaneous lesions (Nail fold infarcts, rashes, splinter 
haemorrhages). In contrast severe life threatening tissue infection may 
develop when there is involvement of large blood vessels by 
leucocytoclastic or necrotizing vasculitis. 
iv) Lung involvement: 
1. Pleurisy: 
The fluid has more protein, low glucose, low complement levels 
and is typically positive for RA factor. 
2. Nodules (Caplan syndrome): 
More in upper than lower zones.  Cavitation may occasionally lead                          
to haemoptysis. 
3. Pulmonary fibrosis: 
It causes progressive dyspnoea, clubbing of fingers, fine late 
inspiratory crepitations. 
4. Obliterative Bronchiolitis: 
Manifesting with an acute onset of breathlessness. Many patients 
have evidence of airway obstruction. Bronchiectasis also appears to 
be more common.  
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v) Cardiac involvement: 
1. Pericardial effusion can be found by ultra-sonography in 
patients with seropositive nodular disease.  Constrictive 
pericarditis is more common and presents with dyspnoea, right 
sided heart failure, peripheral oedema.  
2. Valvulitis: Granulomatous thickening of the cusps of the aortic 
valve occurs more frequently than in the mitral valve, rarely 
producing incompetence. 
vi) Eye involvement: 
Common in RA and may be due to localized tissue 
involvement. 
1. Episcleritis: 
Appears as a raised lesion in the anterior sclera with 
hyperaemia of the deeper layers. 
2. Scleritis: 
Is less common and may lead to progressive thinning of the 
sclera (scleromalacia) and even perforation. 
3. Keratoconjunctivitis sicca  (dry eyes) due to secondary 
Sjogren’s syndrome. 
4. Corneal melting is a rare manifestation.  Clinical features are  
pain, redness and blurred vision with corneal thinning. 
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vii) Peripheral Nerve involvement: 
Peripheral neuropathies can be produced by  proliferating 
synovium causing compression of nerves.  A mild glove and 
stocking sensory neuropathy is relatively common in RA.  
viii) Muscle involvement: 
Is attributed to the reflex inhibition and wasting  resulting 
from severe joint pain. 
ix) Liver pain: 
There may be mild hepatosplenomegaly and   asymptomatic 
elevation of the serum alkaline phosphatase. 
x) Bone involvement: 
Juxta – articular osteoporosis is an early feature.  A small 
proportion of patients may develop osteomalacia. 
xi) Felty’s syndrome: 
Lymphadenopathy is common.  It is more obvious in  
patients with Felty syndrome (Rheumatoid arthritis, Splenomegaly, 
Leucopenia).  Other features include anaemia, thrombocytopenia, 
persistent vasculitic leg ulceration, cutaneous pigmentation, weight 
loss and recurrent infection. 
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DIAGNOSIS: 
 The American College of Rheumatology (1988 revised) developed 
the following criteria for the classification of rheumatoid arthritis. 
1. Morning Stiffness: This occurs in and around the joints and 
lasts at least 1 hour before maximal improvement. 
2. Arthritis of 3 or more joint areas: At least 3 joint areas 
simultaneously have soft tissue swelling or fluid (not bony 
overgrowth) observed by a physician.  The 14 possible areas are 
right or left proximal interphalangeal (PIP), 
metatarsophalangeal (MTP) joints. 
3. Arthritis of hand joints of at least one area swollen in a wrist, 
MCP, or PIP joint. 
4. Symmetric arthritis with simultaneous involvement of the same 
joint areas on both sides of the body.  Bilateral involvement of 
PIPs, MCPs, and MTPs is acceptable without absolute 
symmetry. 
5. Rheumatoid nodules: Subcutaneous nodules are present over 
bony prominences or extensor surfaces or in juxta-articular 
regions.  
6. Serum Rheumatoid Factor: Abnormal amounts of serum RF 
are demonstrated by any method for which the result has been 
positive in fewer than 5% of healthy control subjects.  
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7. Radiographic changes typical of RA on posteroanterior hand 
and wrist radiographs, which must include erosions or 
unequivocal bony decalcification localized in or most marked 
adjacent to the involved joints. Osteoarthritic changes alone do 
not qualify. 
A patient can be classified as having RA if 4 of 7 criteria are 
present. Criteria 1- 4 must be present for at least 6 weeks, and a physician 
must observe criteria 2 - 5. These criteria are intended as a guideline for 
classification of patients, often for research purposes. They do not 
absolutely confirm or exclude a diagnosis of RA in a particular patient, 
especially in those with early arthritis. 
COMPLICATIONS: 
RA is not fatal, but complications of the disease may shorten 
survival by a few years in some individuals. In general, RA is progressive 
and cannot be cured. In some, the disease gradually becomes less 
aggressive and symptoms may even improve. However, if bone and 
ligament destruction and any deformities have occurred, the effects are 
permanent. According to one survey, 70% of patients with RA believe 
that the disease prevents them from living a fully productive life.   
Lymphoma and other cancers: Alterations in the immune system 
associated with RA may play a role in the higher risk for lymphoma 
observed in patients with RA. Aggressive treatments for RA that suppress 
the immune system may help preventing this cancer, but more research is 
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needed to evaluate this possibility. Other cancers that may occur with 
increased frequency in patients with RA include prostate and lung 
cancers.  
Macrophage activation syndrome: This is a life-threatening 
complication of RA and requires immediate treatment. Patients should be 
aware of symptoms, which include persistent fever, weakness, 
drowsiness, and lethargy. 
PROGNOSIS: 
 The following factors at presentation are associated with a poor 
prognosis. 
¾ Higher baseline disability. 
¾ Female gender. 
¾ Involvement of Metatarsophalangeal joints. 
¾ Positive Rheumatoid Factor. 
¾ Disease duration of over 3 months. 
Disease that remains persistantly acting for more than a year is 
likely to lead to joint deformities and disability around 80% will be 
moderately to severely disabled with in 20 years.  The overall mortality 
rate for patients with RA is reportedly 2.5 times that of the general 
population.   Much of the excess mortality derives from infection, 
vasculitis and poor nutrition.  The average life span is reduced by 8 – 15 
years in RA. 
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INVESTIGATIONS: 
 No pathognomonic test is available to confirm the diagnosis of RA; 
instead, the diagnosis is made using clinical, laboratory, and imaging 
features. 
1. Haematological:   
¾ Normochromic normocytic anaemia is frequently present in 
active RA. 
¾ The WBC count is usually normal, but a mild leucocytosis may 
be present. 
¾ Eosinophilia when present usually reflects severe systemic 
disease. 
¾ The Erythrocyte Sedimentation Rate is increased in nearly all 
patients with active RA. 
¾ The levels of acute phase reactants including Ceruloplasmin and 
C-reactive protein are also elevated. 
2. Immunological: 
Rheumatoid factor (RF): 
¾ The presence of rheumatoid factor does not establish the 
diagnosis of RA, but can be of prognostic significance.  RA 
factor are auto antibodies reactive with the Fc position of IgG. 
Presence of RF can be detected by several tests such as Rose 
Waaler, Latex fixation test and other slide agglutination test.  
The test can be employed to confirm a diagnosis in individuals 
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with suggestive clinical presentation and if present in high titer, 
to designate patients at risk for severe systemic disease.  Other 
conditions associated with RA are SLE, chronic liver disease, 
sarcoidosis, interstitial pulmonary fibrosis, hepatitis B, 
tuberculosis, syphilis, malaria. If RF is present in high titres 
(more than 1/40) and if the clinical points favours the diagnosis 
of RA the test can be taken as diagnostic. 
¾ Antinuclear antibodies:  These are present in approximately 
40% of patients with RA. 
¾ Newer antibodies (anti-CCP): Recent studies of antibodies to 
cyclic citrullinated peptide suggest a sensitivity and specificity 
equal to Rheumatoid factor. 
3. Synovial Fluid analysis: 
Confirms the presence of inflammatory arthritis.  The fluid is 
usually turbid, with reduced viscosity, increased protein content. 
 An inflammatory synovial fluid (WBC count > 2000/µL) is present 
with counts generally from 5,000 – 50,000/µL. 
 Usually, neutrophil predominance (60% - 80%) is observed in the 
synovial fluid (in contrast with mononuclear cell predominance in the 
synovium). 
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4. Synovial Biopsy: 
Villus formation with thickening of synovial layer and infiltration 
with abnormal cells. 
5. Radiographic Evaluation: 
Diagnosis is supported by a characteristic pattern of abnormalities 
including tendency towards symmetric involvement. 
¾ Soft tissue changes, juxtoarticular osteoporosis may become 
apparent within weeks of onset. 
¾ Loss of articular cartilage and bone erosion develop after 
months of sustained activities.  Joint space changes, 
alignment, deformities, subluxation, bony ankylosis develops 
in the late stage.  
6. Arthroscopy:  In acute RA synovium is oedematous, diffusely 
erythematous and friable. In more chronic condition it becomes 
thickened. 
7. MRI: Used in patients with abnormalities of the cervical spine.  
8. Sonography: This allows recognition of effusions in joints that are 
not easily accessible. High resolution ultrasound images may allow 
visualization of tendon sheaths, changes and degree of 
vascularization of the synovial membrane and even erosions.  
9. Bone Scanning: Findings may help to distinguish inflammatory 
from non-inflammatory changes in patients with minimal swelling. 
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10. Densitometry: Findings are useful to diagnose changes in bone 
mineral density indicative of osteoporosis. 
11. Other Tests:  HLA – DR4 may constitute a helpful marker in early 
undifferentiated arthritis. 
12. Other Procedures:  Joint aspiration, and biopsies (skin, nerve, 
rectum and kidney) maybe considered if vasculitis is suggested. 
13. Urine analysis, Bio-Chemical analysis. 
DIFFERENTIAL DIAGNOSIS: 
¾ Acute viral arthritis (Rubella, Hepatitis B, Parvovirus) 
¾ Bacterial endocarditis 
¾ Acute Rheumatic fever 
¾ Sarcoidosis 
¾ Reactive arthritis (Reiter’s disease) 
¾ Psoriatic arthritis 
¾ Inflammatory bowel disease 
¾ Systemic Lupus Erythematous 
¾ Sjogren’s syndrome 
¾ Polymyositis 
¾ Vasculitis syndrome 
¾ Polyarticular gout 
¾ Calcium pyrophosphate disease 
¾ Osteoarthritis. 
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JUVENILE RHEUMATOID ARTHRITIS: 
 The American College of Rheumatology has defined it as arthritis 
of one or more joints with onset below the age of 16 years and persisting 
for atleast 6 weeks with explicit exclusion of other specific diseases such 
as juvenile ankylosing spondylitis, juvenile psoriatic arthritis, infectious 
and post infectious arthritis and other rheumatic diseases.  Prevalence is 
in the range of 0.4 – 1.3 per 1000 children. 
 Juvenile Rheumatoid Arthritis is an autoimmune disease with 
major histocompatibility complex (MHC) associated with genetic 
predisposition.  The classical IgM, Rheumatoid Factor is usually negative 
but is believed that some children have hidden IgA Rheumatoid Factor. 
CLINICAL FEATURES: 
 Three major types of onset are described according to the 
presentation during first 6 months of disease.   
1. Pauciarticular onset JRA: 
This accounts for about 60% of patients. Four or less joints usually 
large are involved in an asymmetrical fashion.  Joint swelling rather than 
joint pain is the usual complaint. 
2. Polyarticular onset JRA: 
Occurs in 30% of patients and is common in girls.  Five or more 
joints (both large and small) are affected within the first 6 months of 
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onset. Increased joint pain in proportion to the degree of joint swelling is 
the usual complaint.  Fever and malaise can be significant.  
3. Systemic onset JRA: 
About 10% of patients with JRA may have an acute onset of the  
disease with prominent systemic features that may precede the joint 
manifestation. Illness usually begins as an intermittent fever with a 
characteristic peak, twice daily.  This is accompanied by a characteristic 
maculopapular rash with central clearing.  Hepatosplenomegaly and 
lymphadenopathy are common.  Pericarditis and interstitial lung disease 
may be present.  Antinuclear antibodies are positive but rheumatoid 
factor is negative.  
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MATERIALS AND METHODS 
 The disease “Udhira Vatha Suronitham” has been dealt in the 
book “Yugi Vaithya Chinthamani”.  The clinical study on Udhira Vatha 
Suronitham was done in Post Graduate Department of Podhu 
Maruthuvam, Government Siddha Medical College, Palayamkottai.  The 
study involved 20 In-Patients and 20 Out-Patients of either sex.   
Selection of Patients: 
 Patients with following criteria were screened and selected for 
study.   
¾ Pain and swelling in minor joints of hand and feet 
¾ Swelling of ankle and knee joints 
¾ Swelling of hind foot  
¾ Fatigue  
¾ Anorexia 
¾ Pyrexia 
Evaluation of clinical parameters: 
 In this study, a detailed clinical history regarding the patient’s age, 
occupation, socio-economic status was recorded at the time of admission 
or first visit.  Special attention was laid on the joint pain, swelling, early 
morning stiffness, regarding their nature, site of occurrence, mode of 
onset, deformity and severity.  The seasonal variation and precipitating 
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factors like emotional stress, trauma and change of climate were 
enquired.  Constitutional symptom like easy fatiguability, anorexia, loss 
of weight, pyrexia were noted. Extra articular features like conjunctivitis, 
iritis, episcleritis, vasculitis etc., were noted.   
Study of siddha aspect of diagnosis: 
 A case sheet was prepared on the basis of siddha methodology i.e. 
Poriyal Arithal, Pulanal Arithal, Vinathal, Uyir Thathukkal, Udal 
Kattugal, Envagai Thervugal etc. In addition an individual case sheet was 
maintained for each case in the In-Patient ward. 
Clinical investigations: 
 The diagnostic test such as blood test TC, DC, ESR, Hb, Sugar, 
Urea, Serum Cholesterol, Rheumatoid factor, Urine analysis for sugar, 
Albumin, Deposits and stool examination for Ova and cyst were carried 
out to rule out any systemic illness.  
Pharmacological evaluation of the trial medicines and acute 
toxicity study of internal trial medicine were conducted at the 
Pharmacology Department in Government Siddha Medical College, 
Palayamkottai.  Bio–chemical analysis of the test medicine was 
conducted at the Department of Bio–chemistry in Government Siddha 
Medical College, Palayamkottai. 
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Management: 
 The treatment is aimed to neutralize the vitiated vatham, pitham 
and kabham. 
The trial medicine used in the present study are as follows. 
1. Kirubagara Shanmuga Chenduram – 130mg with Chukku, Milagu and 
Omam Choornam - 1g with Murungai Pattai Chaaru, twice daily 
(internal). 
2. Vathathirkku Poosa Nochi Ennei (external application). 
 Further the patients were kept in dietic restriction and adviced to do 
pranayamam, joint exercises to maintain the general well-being of the 
individuals. 
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RESULTS AND OBSERVATION 
 For the clinical study, 20 In-patients and 20 Out-patients were 
selected and treated in PG-I, Pothu Maruthuvam Department, G.S.M.C 
Hospital, Palayamkottai.  Results were observed with respect to the 
following criteria. 
1. Sex distribution 
2. Age distribution 
3. Religion 
4. Thinai 
5. Paruvakaalam 
6. Socio-economic status 
7. Aetiological factors 
8.  Mode of onset 
9.  Duration of illness 
10. Clinical manifestations 
11. Associated symptoms 
12. Systemic examination 
13.  Individual joint involvement 
14. Deformities of joints 
15. Gradation of pain, joint swelling and restricted   
  movements 
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16. Grading of Rheumatoid arthritis 
17. Disturbances in Mukkutram 
a. Derangement of Vatham 
b. Derangement of Pitham 
c. Derangement of Kabham 
18. Involvement of Ezhu Udal Thathukkal 
19. Envagai Thervugal 
20. Grading of results. 
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1. Sex Distribution: 
Table – 1. Illustrates sex distribution and its relative percentage. 
SI. 
No. 
Sex 
In -  Patients Out - Patients 
No. of 
Cases 
Percentage
No. of 
Cases 
Percentage
1 Male 5 25 2 10 
2 Female 15 75 18 90 
 
 From the above table, it is clear that the incidence is more in 
females. 
 
 
Sex Distribution 
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2. Age Distribution: 
Table – 2. Illustrates age distribution and its relative percentage. 
SI. 
No. 
Age 
In -  Patients Out - Patients 
No. of 
Cases 
Percentage
No. of 
Cases 
Percentage
1 11-20 yrs - - - - 
2 21-30 yrs 1 5 4 20 
3 31-40 yrs 2 10 4 20 
4 41-50 yrs 7 35 5 25 
5 51-60 yrs 5 25 4 20 
6 
61 and 
above 
6 30 3 15 
 
The above table shows that the incidence is more in 4th, 5th and 6th 
decades.   
Age Distribution 
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In siddha literature, age of the individual is fixed as 100 and is 
divided into 3 Kaalam as  
Vatha Kaalam  - First 33 years and 4 months,  
 Pitha Kaalam  - Second 33 years and 4 months, 
 Kabha Kaalam - Third 33 years and 4 months. 
Out of 20 In-patients, 10% of the cases were in Vatha Kaalam, 
80% of cases were in Pitha Kaalam and 10% of the cases were in Kabha 
Kaalam. 
Out of 20 Out-patients, 75% of the cases were in Pitha Kaalam.  
This shows that majority of the cases were affected in Pitha Kaalam. 
3. Religion 
Table – 3.  Illustrates the incidence of disease with respect to religion 
SI. 
No. 
Religion 
In -  Patients Out - Patients 
No. of 
Cases 
Percentage
No. of 
Cases 
Percentage
1 Hindus 16 80 18 90 
2 Muslims 4 20 2 10 
3 Christians - - - - 
  
 This shows that the incidence is more among Hindus. 
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4. Thinai: 
Table - 4. Illustrates the distribution with respect to Thinai (the 
habitat of the patients). 
SI. No Thinai 
In -  Patients Out - Patients 
No. of Cases Percentage No. of Cases Percentage 
1 Kurinji - - - - 
2 Mullai - - - - 
3 Marutham 19 95 20 100 
4 Neithal 1 5 - - 
5 Paalai - - - - 
 
The above table shows, most of the patients were from Marutha Nilam. 
5. Paruva Kaalam: 
Table – 5. Illustrates the incidence of the disease with respect to 
Kaalam. 
SI. No. Paruva Kaalam 
In -  Patients Out - Patients 
No. of Cases Percentage No. of Cases Percentage 
1 Kaar kaalam - - - - 
2 Koothir kaalam 1 5 2 10 
3 Munpani kaalam 7 35 5 25 
4 Pinpani kaalam 9 45 12 60 
5 Elavenir kaalam 3 15 1 5 
6 
Mudhuvenir 
kaalam 
- - - - 
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 From the above table it is clear that majority of patients were 
admitted in Munpani and Pinpani Kaalam. 
Paruva kaalam 
6. Socio-Economic status: 
Table – 6. Illustrates the Socio-Economic status. 
SI. No 
Socio-Economic 
Status 
In -  Patients Out - Patients 
No. of Cases Percentage No. of Cases Percentage 
1 Rich - - - - 
2 Middle class 3 15 6 30 
3 Poor 17 85 14 70 
 
The above table shows, most of the patients affected by this disease 
belongs to Poor Socio-Economic status. 
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7. Aetiological factors: 
Table – 7. Illustrates the Aetiological factors. 
SI. 
No. 
Aetiological 
factors 
In -  Patients Out - Patients 
No. of 
Cases 
Percentage
No. of 
Cases 
Percentage
1 Positive family 
history 
4 20 3 15 
2 Positive previous 
history 
7 35 6 30 
3 Miscellaneous 9 45 11 55 
 
 The above table shows that most of the patients had Miscellaneous 
causes. 
8.  Mode of Onset: 
Table – 8. Illustrates the Mode of Onset. 
SI. 
No. 
Mode of 
Onset 
In -  Patients Out - Patients 
No. of 
Cases 
Percentage
No. of 
Cases 
Percentage
1 Acute 3 15 4 20 
2 Gradual 17 85 16 80 
 
 The above table shows that most of the cases had gradual onset. 
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9. Duration of Illness: 
Table – 9. Illustrates the Duration of Illness. 
SI. 
No. 
Duration of 
Illness 
In -  Patients Out - Patients 
No. of 
Cases 
Percentage
No. of 
Cases 
Percentage
1 Below 1 month 1 5 1 5 
2 1-3 months 2 10 3 15 
3 3-6 months 3 15 4 20 
4  6-9 months 9 45 7 35 
5  9 months-1year 3 15 2 10 
6  More than 1 
year 
2 10 3 15 
 
From the table it is clear that most of the cases were affected with 
the duration of 6 - 9 months. 
10. Clinical Manifestations:  
Table – 10. Illustrates the Symptoms of the Disease. 
SI. No. Symptoms 
In -  Patients Out - Patients 
No. of Cases Percentage No. of  Cases Percentage
1 Joint Pain  20 100 20 100 
2 Swelling of the joints 20 100 20 100 
3 Easy fatiguability 20 100 20 100 
4 Fever 12 60 10 50 
5 Loss of appetite 17 85 18 90 
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The above table shows that all the patients presents with the main 
clinical features of joint pain, swelling of joints and fatigue. 
Clinical Manifestations 
11.  Associated Symptoms: 
Table – 11. Illustrates the associated symptoms. 
SI.  
No 
Associated  
Symptoms 
In -  Patients Out - Patients 
No. of Cases Percentage No. of Cases Percentage 
1 Morning stiffness 20 100 10 100 
2 Restriction of movements 20 100 10 100 
3 Difficulty to walk 8 40 1 10 
4 Neck pain 3 15 2 10 
5 Sleeplessness 9 45 6 30 
6 Constipation 12 60 9 45 
 From the above table it is clear that all the patients had early 
morning stiffness and restriction of movements. 
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12. Systemic Examination (Extra articular features): 
Table – 12. Illustrates signs of Systemic Examination.  
SI. No Signs 
In -  Patients Out - Patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Subcutaneous nodules 6 30 4 20 
2 Muscle wasting 8 40 6 30 
3 Ophthalmic 
manifestation 
- - - - 
4 Hepatomegaly - - - - 
5 Splenomegaly - - - - 
6 Respiratory system - - - - 
7 Cardiovascular system - - - - 
8 Nervous system 3 15 2 10 
 
Out of 20 In-Patients, 30% of the cases had subcutaneous nodules, 
40% of the cases had muscle wasting and 15% of the cases had central 
nervous system involvement. 
Out of 20 Out-Patients, 20% of the cases had subcutaneous 
nodules, 30% of the cases had muscle wasting and 10% of the cases had 
central nervous system involvement. 
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13. Individual joints involvement: 
Table – 13. Illustrates the incidence of individual joints involvement. 
SI. 
No. 
Joints involved 
In -  Patients Out - Patients 
No. of 
Cases 
Percentage
No. of 
Cases 
Percentage
1 Proximal inter 
phalangeal Joints 
20 100 20 100 
2 Metacarpo-
phalangeal Joints 
20 100 20 100 
3 Wrist Joint 20 100 20 100 
4 Elbow Joint 8 40 9 45 
5 Shoulder Joint 5 25 6 30 
6 Temporomandibular 
Joint 
- - - - 
7 Sternoclavicular Joint 2 10 1 5 
8 Cervical spine  3 15 2 10 
9 Thoracic spine - - - - 
10 Lumbar spine 2 10 3 15 
11 Hip Joint 2 10 1 5 
12 Knee Joint 18 90 17 85 
13 Ankle Joint 20 100 18 90 
14 Meta-tarso phalangeal 
Joints 
12 60 11 55 
From the above table it is clear that in all the patients proximal 
interphalangeal joints, metacarpo-phalangeal joints, wrist joint gets 
affected. 
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14. Deformity of Joints: 
Table – 14. Illustrates the distribution with respect to Deformity of 
Joints. 
S. 
No 
Deformity 
In-Patients Out-Patients 
No of 
cases 
Percentage
No of 
cases 
Percentage
1 Swan neck deformity 1 5 2 10 
2 Foot deformity 2 10 3 15 
3 Boutonniere deformity 1 5 - - 
4 Ulnar deviation of 
fingers 
- - 1 5 
 
From the table it is clear that in both Out-Patients and In-Patients 
15% and 10% of the cases had foot deformity.  
 Swan neck deformity was seen in 5% of In-patients and 10% of  
Out-patients.  
 Boutonniere deformity was seen in 5% of In-patients. 
 Ulnar deviation of fingers was seen in 5% of Out-patients. 
  
 
 
87
15. Gradation of Pain, Joint swelling and restriction of movements 
Table – 15. Illustrates the grades of signs and symptoms. 
S. 
No. 
Signs and 
symptoms 
In-Patients Out-Patients 
Mild Moderate Severe Mild Moderate Severe 
No. 
of 
cases 
% 
No. 
of 
cases
%
No. 
of 
cases
%
No. 
of 
cases
%
No. 
of 
cases 
% 
No. 
of 
cases
%
1 Pain 5 25 8 40 7 35 6 30 10 50 4 20
2 Joint 
swelling 
6 30 9 5 5 25 10 50 8 40 2 10
3 Restriction 
of 
movements 
5 25 10 50 5 25 7 35 10 50 3 15
4 Muscle 
wasting 
4 20 4 20 - - 2 10 4 20 - - 
 
 From the above table it is clear that most of the patients have 
moderate pain, joint swelling and restriction of movements. 
 Among 20 In-Patients, muscle wasting is mild in 20% of cases and 
moderate in 20% of cases.  Among 20 Out-Patients, muscle wasting is 
mild in 10% of cases and moderate in 20% of cases.  No severe muscle 
wasting was noted. 
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16. Grading of Rheumatoid Arthritis: 
Table – 16. Illustrates the Grading of Rheumatoid Arthritis. 
SI. 
No 
Grading of rheumatoid 
arthritis 
In -  Patients Out - Patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 
I – no restriction in 
normal activities 
- - - - 
2 II – moderate restriction 5 25 7 35 
3 III – marked restriction 13 75 13 65 
4 IV – confined to bed 2 10 - - 
 
Most of the cases belong to grade III with marked restriction and 
inability to perform day-to-day activities. 
Grading of Rheumatoid Arthritis 
 
 
 
89
0
10
20
30
40
50
60
70
80
90
100
Pe
rc
en
ta
ge
In ‐  Patients Out ‐ Patients
Praanan
Abaanan
Viyaanan
Udhaanan
Samaanan
Naagan
Koorman
Kirukaran
Devathathan
Dhananjeyan
17. Disturbances in Mukkutram: 
Table – 17. Illustrates the disturbances in Mukkutram. 
a. Disturbances in Vatham: 
SI. No Vatham 
In -  Patients Out - Patients 
No. of Cases Percentage No. of Cases Percentage 
1 Praanan - - - - 
2 Abaanan 12 60 9 45 
3  Viyaanan 20 100 20 100 
4 Udhaanan - - - - 
5 Samaanan 20 100 20 100 
6 Naagan - - - - 
7 Koorman 11 55 5 25 
8 Kirukaran 17 85 18 90 
9 Devathathan 9 45 6 30 
10 Dhananjeyan - - - - 
In all the cases Viyaanan, Samaanan gets affected. 
Disturbances in Vatham 
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b. Disturbances in Pitham: 
SI. No Pitham 
In -  Patients Out - Patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Anal pitham 17 85 18 90 
2 Ranjaga pitham 9 45 11 55 
3  Prasaga pitham 4 20 5 25 
4 Alosaga pitham 11 55 5 25 
5 Saathaga pitham 20 100 20 100 
 
All the cases gets affected with Sathaga pitham and in most 
of the cases Anal pitham gets affected. 
 
Disturbances in Pitham 
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c. Disturbances in Kabham: 
 SI. No Kabham In -  Patients Out - Patients 
No. of 
Cases 
Percentage No. of 
Cases 
Percentage 
1 Avalambagam 20 100 20 100 
2 Kilethagam 17 85 18 90 
3  Pothagam  - - - - 
4 Tharpagam - - - - 
5 Santhigam 20 100 20 100 
 
Table shows that all the cases gets affected with 
Avalambagam and Santhigam. 
 
Disturbances in Kabham 
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18. Involvement of Udal Thathukkal: 
Table – 18. Illustrates the Involvement of Seven Udal Thathukkal. 
SI. No Udal thathukkal 
In -  Patients Out - Patients 
No. of Cases Percentage No. of Cases Percentage 
1 Saaram 20 100 20 100 
2 Senneer 20 100 20 100 
3  Oon  20 100 20 100 
4  Kozhuppu 20 100 20 100 
5 Enbu 20 100 20 100 
6 Moolai - - - - 
7 Sukkilam/Suronitham - - - - 
 
Table shows, in all the cases Saaram, Senneer, Oon, Kozhuppu and 
Enbu gets affected 
         Disturbances in Udal Thathukkal 
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19. Envagai Thervugal: 
Table – 19. Illustrates the condition seen in Envagai Thervugal. 
SI. No Envagai thervugal 
In -  Patients Out - Patients 
No. of Cases Percentage No. of Cases Percentage 
1 Naa 20 100 20 100 
2 Niram 4 20 5 25 
3  Mozhi - - - - 
4 Vizhi 11 55 5 25 
5 Malam 12 60 9 45 
6 Moothiram 
Neerkuri 
 
- 
 
- 
 
- 
 
- 
Neikuri 
      Vatha neer 
Aravil Aazhi 
   Aazhiyil Aravu 
 
3 
8 
9 
 
15 
40 
45 
 
2 
9 
8 
 
10 
45 
40 
7 Sparisam 20 100 20 100 
8 Naadi 
     Vatha Pitham 
     Pitha Vatham 
 
15 
5 
 
75 
25 
 
13 
7 
 
65 
35 
 
 In all the cases, Naa, Sparisam gets affected.  In all the cases 
Neerkuri and Neikuri was studied. 
Most the cases showed Vatha Pitha Naadi and a few showed Pitha 
Vatha Naadi.  
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20. Gradation of Results: 
Table – 20. Illustrates the Gradation of results. 
SI. 
No 
Gradation of 
results 
In -  Patients Out - Patients 
No. of 
Cases 
Percentage
No. of 
Cases 
Percentage
1 Good  16 80 15 75 
2 Fair 2 10 4 20 
3 Poor 2 10 1 5 
 
 Out of 20 In-Patients, 80% of cases showed good response and 
10% cases fair response.  Out of 20 Out-Patients, 75% of cases showed 
good response and 20% of cases showed fair response.Poor response was 
seen 10% of IP cases and 5% of OP cases. 
 
Gradation of Results 
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DISCUSSION 
 “Uthira Vatha Suronitham”, a Vatha disease mentioned by Yugi 
Muni causes a large burden on society interms of direct costs and indirect 
costs from psychosocial and economic factors.  Despite significant 
advances over the past decades, Uthira Vatha Suronitham continues to be 
a challenging disease with exacerbation and remission.  The clinical 
variability of which suggests that it might represent the end result of a 
number of different disease pathways.  Therefore a vigorous search is 
underwent to find out a new medicine for effective cure. 
 The characteristic features of “Uthira Vatha Suronitham” are 
¾ Pain and Swelling of peripheral joints. 
¾ Anorexia 
¾ Fatigue 
¾ Fever etc.  
 The disease has been compared with the “Rheumatoid Arthritis” in 
modern clinical entity.  The similarities of the disease has been studied in 
detail through their clinical features, diagnostic criteria of American 
Collge of Rheumatology and investigations. 
 20 Out-Patients and 20 In-Patients were selected based on both 
siddha and Modern parameters and were given the trial drugs. The 
patients were treated for a period of 20-50 days. Out-Patients were 
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reviewed once in two days and clinical and pathological assessment for 
In-Patients were carried out daily. 
 A detailed history including Age, Sex, Socio-economic status, 
Occupation, Family History, Paruva Kaalam etc were observed regarding 
their influence in the causation of disease and its aggravation. 
Sex Distribution: 
 Among  20 In-Patients, 25% were males and 75% were females. 
 Among  20 Out-Patients, 10% were males and 90% were females. 
 From this study it is clear that the incidence was higher in females 
than in males indicating Udhira Vatha Suronitham is predominant in 
females. 
Age Distribution: 
 The study reveals that the incidence of disease was more 
predominant in 4th, 5th and 6th decades of life which correlates with actual 
incidence of the disease during 4th and 5th decades mentioned in literature.  
Further it was concluded that majority of cases were affected in their 
Pitha Kaalam (i.e. Middle 33 years and 4 months). 
Religion: 
 The incidence is more among Hindus.  This may be due to the 
existence of higher proportion of Hindus in the society.  
Thinai: 
 Out of 20 In-Patients, 95% of the cases were from Marutha Nilam 
and 5% of the cases were from Neithal Nilam, which is prone for vatha 
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diseases.  All the Out-Patients were from Marutha Nilam.  According to 
siddha literature Marutha Nilam is “Disease free zone”.  The result does 
not coincide with the literature.  This may be due to alteration in food 
habits and activities. 
Paruva kaalam: 
 Udhira Vatha Suronitham basically a vatha disease was common 
during Muthuvenir Kaalam and Kaar Kaalam in which the vatham gets 
increased. But the incidence of disease gets aggravated in Munpani and 
Pinpani Kaalam.This is due to variation in food habits, life style and 
climatic conditions. 
Socio-Economic Status: 
 Majority of the cases belonged to poor economic conditions where 
malnutrition, lowered immune responses and emotional stress made them 
more prone to this disease. 
Aetiological Factors: 
 Out of 20 In-Patients, 20% of the cases had positive family history, 
35% of the cases had positive previous history and 45% of the cases had 
miscellaneous causes.   
 Out of 20 Out-Patients, 15% of the cases had positive family 
history, 30% of the cases had positive previous history and 55% of the 
cases had miscellaneous causes.  This shows that the aetiology for the 
cause of the disease remains unknown. However change in  food habits, 
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life style all predispose to the dearrangement of three humors resulting in 
the causation of disease.  
Mode of Onset: 
 Out of 20 In-Patients, 85% of the cases had gradual onset and 15% 
of the cases had acute onset. 
 Out of 20 Out-Patients, 80% of the cases had gradual onset and 
20% of the cases had acute onset. Failure to follow medical advice 
regarding dietary restrictions, stress and strain, change in life style all 
accounts for the disease to become chronic.  
Duration of Illness: 
 Most of the cases were affected with the duration of illness 
between 6 – 9 months.  10% of IP cases and 15% of OP cases were 
affected with duration of illness of more than 1 year.  
Clinical Manifestations: 
Among 20 In-Patients, all the cases had joint pain, swelling, 
morning stiffness, restriction of movements and easy fatiguability, 85% 
of the cases had loss of appetite, 60% of the cases had constipation, 45% 
of the cases had sleeplessness, 40% of the cases had difficulty in walking, 
60% of the cases had fever and 15% of the cases had neck pain. 
 Among 20 Out-Patients, all the cases had joint pain, swelling, 
morning stiffness, restriction of movements and easy fatiguability, 90% 
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of the cases had loss of appetite, 45% of the cases had constipation, 30% 
of the cases had sleeplessness, 50% of the cases had fever, 10% of the 
cases had difficulty in walking and 10% of the cases had neck pain. 
 Joint pain was classified into mild, moderate and severe.  Out of 20 
In-Patients, mild pain was observed in 25% of the cases, moderate pain in 
40% of the cases and severe pain in 35% of the cases.  
 Out of 20 Out-Patients, mild pain was observed in 30% of the 
cases, moderate pain was observed in 50% of the cases and severe pain in 
20% of the cases. 
 Swelling of joints was noticed in all the cases and was measured by 
means of a non-elastic measuring tape.  Area of maximum level of 
swelling around the joints was measured both before and after treatment.  
The joints subjected to measurements were knee joint, wrist joint, 
proximal interphalangeal joints of hand.  
 Out of 20 In-Patients, mild swelling was observed in 30% of cases, 
moderate swelling in 45% of cases and severe swelling in 25% of cases. 
 Out of 20 Out-Patients, mild swelling was observed in 50% of 
cases, moderate swelling in 40% of cases and severe swelling in 10% of 
cases. 
 Measurements taken after the treatment reveals that, out of 20     
In- Patients 80% of the cases had marked reduction in swelling and 20% 
of  the cases had moderate reduction in swelling.  Out of 20 Out-Patients, 
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65% of the cases under regular treatment had marked reduction in 
swelling and 30% of the cases had moderate reduction in swelling.  After 
treatment, the early  morning stiffness which occurred for a period of  1 – 
3 hrs has been reduced to 10 – 20 mins.  Restriction of movements were 
seen in all the cases.  Since facilities are inadequate (Goniometer) 
restriction of movement of the patients were assessed by asking the 
patients to move the joint in a particular direction.  When the active 
movements were impossible, movements were considered as restricted.  
After treatment with the trial drug, most of the cases had increased range 
of movements. 
Systemic Examination: 
 Out of 20 In-Patients, 30% of the cases had subcutaneous nodules, 
40% of the cases had muscle wasting and 15% of the cases had  nervous 
system involvement (Exaggerated Deep Tendon Reflexes). 
 Out of 20 Out-Patients, 20% of the cases had subcutaneous 
nodules, 30% of the cases had muscle wasting and 10% of the cases had 
nervous system involvement. 
Incidence of Individual Joint Involvement: 
 Out of 20 In-Patients, all the cases had the involvement of 
proximal interphalangeal, metacarpo phalangeal joints, wrist joint and 
ankle joint,  90% of the cases had the involvement of knee joints, 40% of 
the cases had the involvement of elbow joints, 60% of the cases had the 
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involvement of metatarso phalangeal joints, 25% of the cases had the 
involvement of shoulder joints, 10% of the cases had the involvement of 
sternoclavicular joint, hip joint and lumbar spine and 15% of the cases 
had the involvement of cervical spine. 
 Out of 20 Out-Patients all the cases had the involvement of PIP, 
MCP and wrist joints, 85% of the cases had the involvement of knee 
joints, 45% of the cases had the involvement of elbow joints and 30% of 
the cases had the involvement of shoulder joints.   Cervical spine and 
lumbar spine gets affected in 10% and 15% of the cases respectively.  
This study reveals that in majority of the cases, the smaller and peripheral 
joints are involved.  
Deformity of Joints: 
 Irregular food habits, change in life style,lack of joint motion, 
stress all accounts for the deformity of joints.   
 Among 20 IP cases, 10% of the cases showed foot deformity, 5% 
of cases showed button hole deformity. 
 Among 20 OP cases, 15% showed foot deformity, 10% showed 
swan neck deformity, 5% showed ulnar drift of hand.  
Grading of Rheumatoid Arthritis (Functional status): 
 Grading of rheumatoid arthritis was done to assess the severity of 
the disease.   
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Grade I  - No restriction to perform normal activities. 
 Grade II - Moderate restriction but with adequate ability to  
   perform most of the activities of day-to-day life  
   despite some discomfort or limitation of motion. 
Grade III - Marked restriction with inability to perform most     
                      activities of daily life, occupation. 
Grade IV - Incapacitation, with confinement to bed or wheel  
  chair. 
Among 20 In-Patients, 25% of the cases belonged to Grade II, 75% 
of the cases belonged to Grade III and 10% of the cases belonged to 
Grade IV. 
 Among 20 Out-Patients, 35% of cases belonged to Grade II and 
40% of the cases belonged to Grade III. 
Disturbances in Vatham: 
 Among 20 In-Patients and 20 Out-Patients, Viyaanan and 
Samaanan gets affected in all the cases leading to pain and restriction of 
movements in joints.  Abaanan gets affected in 60% of In-Patients and 
45% of Out-Patients producing constipation.  Koorman gets affected in 
55% of In-Patients and 25% of Out-Patients leading to disturbance of 
vision due to cataract formation.  Kirukaran gets affected in 85% of In-
Patients and 90% of Out-Patients producing loss of appetite.  
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Devathathan was dearranged in 45% of In-Patients and 30% of            
Out-Patients producing sleeplessness. 
Disturbances in Pitham: 
 Among 20 In-Patients and 20 Out-Patients, Saathaga Pitham was 
affected in all the cases causing difficulty in carrying out day-to-day 
activities, Anal Pitham was affected in 85% of In-Patients and 90% of 
Out-Patients causing loss of appetite.  Ranjaga Pitham was affected in 
45% of In-Patients and 55% of Out-Patients producing anaemia.  Prasaga 
Pitham was affected in 20% of In-Patients and 25% of Out-Patients 
producing pallor of the skin.  Alosaga Pitham was affected in 55% of     
In-Patients and 25% of Out-Patients causing disturbance of vision due to 
cataract formation in the eyes.  
Disturbances in Kabham: 
 Among 20 In-Patients and 20 Out-Patients, Avalambagam and 
Santhigam gets affected in all the cases.  Affected Santhigam causes pain 
and swelling of joints.  Kilethagam gets affected in 85% of In-Patients 
and 90% of Out-Patients leading to loss of appetite.  Since Santhigam and 
Kilethagam gets affected, Avalambagam also gets dearranged. 
Involvement of Seven Udhal Thathukkal: 
 Among 20 In-Patients and 20 Out-Patients, Saaram, Senneer, Oon, 
Kozhuppu and Enbu was affected in all the cases. 
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 Affected Saaram produced fatigue in patients. 
Affected Senneer produced reduction in udal vanmai  
(Anaemia, increased ESR, positive rheumatoid factor). 
 Affected Oon produced muscle wasting. 
 Affected Kozhuppu produced restriction of movements in joints. 
 Affected Enbu produced joint pain, joint deformity. 
Envagai Thervugal: 
 Among 20 In-Patients and 20 Out-Patients, 50% of IP cases and 
60% of OP cases showed Vatha Pitha Naadi, 50% of IP cases and 40% of 
OP cases showed Pitha Vatha Naadi. Naa was affected in all the cases 
producing coated tongue due to constipation or paleness of the tongue 
due to anaemia. 
Niram was affected in 20% of In-Patients and 25% of Out-Patients 
producing pallor of the skin due to anaemia. 
Vizhi was affected in 55% of In-Patients and 25% of Out-Patients 
producing pallor of conjunctiva due to anaemia and in a few disturbance 
of vision due to cataract formation.  
Malam was affected in 60% of In-Patients and 45% of Out-Patients 
producing constipation. 
Sparisam was affected in all the cases producing swelling, 
hyperaemia and warmth in the painful joints and also pallor of skin due to 
anaemia. 
 
106
Regarding Moothiram, neerkuri was normal in all the cases.  
Neikuri showed Vatha Neer (Spread like snake) in 15% of In-Patients and 
10% of Out-Patients. 
40% of In-Patients showed thontha neer with Aravil Aazhi pattern 
and remaining 45% of In-Patients showed thontha neer with Aazhiyil 
Aravu appearance. 
Among the 95% of Out-Patients, 45% showed thontha neer with 
Arvil Aazhi appearance and 40% showed thontha neer with Aazhiyil 
Aravu appearance. 
Investigations: 
 Among 20 In-Patients and 20 Out-Patients, 45% and 55% of 
the cases showed decreased Hb% respectively.  All the cases showed 
increased ESR.  Blood sugar was found to be high in 10% of IP 
cases and 5% of OP cases.  All others showed normal blood sugar, 
urea, serum cholesterol and serum bilirubin.  RA factor was positive 
in 60% of Out-Patients and 55% of In-Patients.  Anti-Nuclear 
Antibodies (ANA) test was done in 2 cases and showed positive 
results.   Synovial fluid analysis was done in One Patient in a private 
lab to differentiate inflammatory arthritis.  It showed abnormalities 
like increased leucocyte count, presence of mucin clot etc.  and 
confirmed the presence of inflammatory arthritis.  At the end of the 
 
107
treatment there was mild rise in Hb%, decrease in ESR and normal 
blood sugar. 
 X-ray of both hands with wrist joints was taken in all the cases 
and it showed soft tissue swelling, reduction in joint spaces, synovial 
thickening, periarticular erosion, osteoporosis, deformities etc 
confirming Rheumatoid arthritis.  X-ray of cervical spine of few 
patients showed cervical spondylosis. 
Management: 
 The main aim of treatment is to keep the Trithodam in 
equilibrium state, and to keep the inflammatory process at a 
minimum there by preserving joint motion, maintaining healthy 
muscles and preventing secondary joint stiffness and deformity, 
constitutional symptoms at a minimum. 
  ‘tpNurdj;jhy; thjk; jhOk;” 
 Hence all the patients were given Agasthiyar Kulambu – 
130mg with Inji Surasam and were put on diet to take only butter 
milk.  The trial drug was given from the next day of viraesanam. 
1. Internally: 
Kirubagara Shanmuga Chenduram – 130mg with Chukku,  
Milagu and Omam Choornam 1gm with Murungai Pattai Chaaru, 
twice daily.  In cases with mild inflammation the drug was given for 
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a period of 20 days and the results were favouring.  In severe joint 
inflammation the drug was given for a period of 20 days.  A gap of 5 
days was given and were adviced to take head bath with omam.  
Again the course was started for a period of 20 days.   So severe 
cases were treated for about 48-50 days. 
2. Externally: 
Vathathirkku Poosa Nochi Ennei was used for external  
application.  All the In-Patients were given thokkanam with the 
medicated oil.  Ottradam was done over the inflammatory joints 
using Tamarind leaves, Vatha Narayanan leaves in few cases. 
 The patients were adviced to follow  
¾ Dietic restrictions  
¾ Savasanam  for 10 minutes 
¾ Deep relaxation technique for 20 minutes 
¾ Physical exercises and 
¾ Life style modifications 
 The ingredients of Kirubaga Shanmuga Chenduram were 
known to possess Anti Vatha Property.  Further the drugs also holds 
the action of Deobstruent, Febrifuge, Alterative, Nutrient etc,  all of 
which contributes to the bringing down of vitiated humors to 
equilibrium state.  Further the drug is administered with Chukku, 
Milagu and Omam Chooranam along with Murungai Pattai Chaaru 
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all of which possess Anti Vatha Property in particular Milagu as got 
anti vatha action.  This inturn helps to pacify the vitiated vatham, 
there by bringing down the other vitiated humors to equilibrium 
state. 
thjNeha; `uk;: 
! ‘muj;ijNah bUkQ;rs; Nfh\;lk; kpe;Jk; 
  mfpy; Njtjhu Kldhk; gypz;Lk; 
  MapYld; Gq;nfUf;F KjpNahh; $e;jy; 
  mWfd; Ntul;lth;f;fQ; rJuf;fs;sp 
  cuj;j rpWKl;bAld; NguhKl;b 
  ASe;JlNd nfhs;sJtpd; FbePh; nehr;rpy; 
  Xq;F khtpyq;if jr%yq;fs;sp 
  Aah; Fg;igNkdp fUk;Nghsq; fhak; 
  gUj;jptpiu ey;nyz;nza; Ntk;gpndz;nza; 
  gfh; rpw;whkzf;nfz;nza; tpsf;fpndz;nza; 
  ghhpYWe; jOjhio foWohAk; 
  gUq;fpue;jp jfuKld; rusq;Ff;fpy; 
  tUj;jkW rjFg;ig apye;ij tpj;Jk; 
  kUjzpAQ; rhuiz Fq;fpypak; tPop 
  thrKWk; G+q;Foyha; nrhy;yf;Nfsha; 
  thjj;jpd; `uq;fnsd tFj;jjhNk” 
   - mfj;jpah; itj;jpa rjfk;> gf;fk; - 40  
! The drugs that are included in the preparation of Nochi Ennei, 
Viz, Nochi, Erukku, Koshtam, Sathakuppai, Gingelly oil were 
known to possess Anti Vatha property thus helping in harassing of 
Vatha disease. 
 
110
Pre-clinical screenings: 
Qualitative analysis of Trial Medicines: 
 The trial medicine Kirubagara Shanumaga Chenduram is 
found to contain the following constituents, Calcium, Sulphate, 
Chloride, Ferrous iron, Unsaturated compound, Mercury all of which 
owes to its action.   
 Calcium constituent is important for the formation of bones 
and helps in treating the osteoporotic changes that occurs in Uthira 
Vatha Suronitham. 
 Iron constituent, essential for the synthesis of Haemoglobin is 
present in the trial medicine in Ferrous form.  This form of iron is 
more soluble and gets readily absorbed from the intestinal lumen.    
Pharmacological Analysis: 
 Pharmacological studies of trial medicine, Kirubagara 
Shanmuga Chenduram showed that it has got significant Analgesic, 
Anti-pyretic and Anti inflammatory action in Albino rats. 
 Pharmacological study of Vathathirkku Poosa Nochi Ennei 
showed that it has got significant Anti inflammatory action in albino 
rats. 
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Toxicological Analysis: 
 Toxicological studies of trial medicine proved that the 
medicines did not produce any untoward effects in Acute toxicity 
study done on albino rats. 
Assessment of Effects of Management: 
 All the 20 In-Patients and 20 Out-Patients were treated with the 
trial medicines.  The results were assessed on the basis of subjective and 
objective improvement in the range of movements, reduction in pain, 
swelling, reduction in erythrocyte sedimentation rate and sense of well 
being.  At the end of treatment the results were categorized as follows. 
Good  -  Complete subsidence of pain, disappearance of  
swelling, improvement in general health and normal 
range of movements of the extremities. 
Fair  -  Relief of pain, reduction in swelling and increased  
range of movements. 
Poor  -  No improvement. 
American College of Rheumatology indicates a responder who has 
showed improvement in the following parameters. 
Improvement in joint counts and improvement in three of the following. 
1. Patient assessment 
2. Physician assessment 
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3. Erythrocyte sedimentation rate 
4. Pain scale 
5. Functional questionaire 
 Among 20 In-Patients,  
80% of the cases showed good response. 
   10% of the cases showed fair response. 
  10% of the cases showed poor response. 
 Among 20 Out-Patients, 
  75% of the cases showed good response. 
  20% of the cases showed fair response. 
  5% of the cases showed poor response. 
 The Poor response is due to lack of dietic restrictions and change in 
life style. 
 After discharge, the patients were advised to attend the Out-
Patients ward of Post Graduate, Podhu Maruthuvam Department for 
further follow up.  During the treatment, dietic restrictions was strictly 
followed.  Patients were instructed to avoid exposure to chill weather and 
to take bath in warm water.  
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SUMMARY 
 Aetiology, pathology, pathogenesis, clinical features, course, 
prognosis of disease were collected from a number of literature both in 
siddha system as well as in modern system of medicine. The aetiology 
lies in the altered equilibrium of three humors (especially vitiated 
vatham) with increased incidence during Pitha Kaalam (4th, 5th decades). 
 The study was done in 40 patients of either sex of varying age 
groups who fulfilled the stipulated criteria.  Out of which 20 patients 
were admitted in the In-Patient ward and 20 patients were treated as Out-
Patients. Diagnosis was done after the evaluation of history, clinical 
features, Envagai thervugal and lab results. Clinical and pathological 
assessment was carried out on the basis of both siddha and modern 
aspects. 
 Trial Medicines were prepared after proper purification.  All the 
patients were treated with Kirubagara Shanmuga Chenduram – 130mg 
with 1gm of Chukku, Milagu and Omam Choornam with Murungai Pattai 
Chaaru twice daily along with the external application of Vathathirkku 
Poosa Nochi Ennei. Patients were observed for 20-50 days.  The 
responses were assessed once in two days for Out-Patients and daily for 
the In-Patients.  No untoward effects were observed clinically in any of 
these cases.  During the course of treatment, patients were advised to 
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follow dietic restrictions, yoga therapy, physical exercises and life style 
modifications.  Clinically marked reduction of pain and swelling in joints, 
reduction in early morning stiffness, increase in the range of movements, 
along with the sense of well being was noted.  The laboratory 
investigation results were also encouraging after the treatment. 
 The ingredients of the trial medicine were found to have anti-vatha 
property pharmacological analysis of the trial drug showed significant 
Analgesic, Anti-pyretic and Anti-inflammatory action.  The external drug 
was also found to possess significant Anti – inflammatory action. 
 Qualitative Analysis of Medicine showed the presence of calcium, 
sulphate, chloride, ferrous iron, unsaturated compound, mercury which 
owes its action.  
 Toxicological studies revealed the safety of the medicine in acute 
toxicity.  
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CONCLUSION 
 Preclinical studies showed significant activity and safety of the trial 
drug.  Treatment of Uthira Vatha Surnoitham patients with the trial drugs 
showed remarkable improvement in reducing the pain and inflammation 
of joints.  No untoward effects were reported during the treatment period. 
 Further followup with trial medicines showed improvement in 
generalized well being as they could carry out their day-to-day activities 
better than earlier.  
 Because of the encouraging results both preclinically and 
clinically, it is concluded that treatment of Uthira Vatha Suronitham 
patients with the trial drugs, Kirubagara Shanmuga Chenduram, 
Vathathirkku Poosa Nochi Ennei will be very effective in the point of 
efficacy and safety. 
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ANNEXURE - I 
PREPARATION AND PROPERTIES OF INTERNAL 
MEDICINE 
KIRUBAGARA SHANMUGA CHENDURAM 
 thiy urk;  - 1 gyk; (35fp) 
 ,ypq;fk;  - 1 gyk; (35fp) 
 tPuk;   - 1 gyk; (35fp) 
 G+uk;   - 1 gyk; (35fp) 
 jhsfk;  - 1 gyk; (35fp) 
 fe;jfk;  - 1 gyk; (35fp) 
 kNdhrpiy  - 1/4 gyk; (8.75fp) 
Rj;jpKiwfs;: 
thiy ,urk; vLf;Fk; tpjk:;  
rpj;jpu %yNth;g;gl;il ehd;Fgq;F vLj;J ,bj;J ,ypq;fj; J}s; 
1 gq;F Nrh;j;J gjq;ff; fUtpapy; ,l;L Kiwg;gb vhpf;f> ,urk; 
Nkw;rl;bapy; xl;bf;nfhs;Sk; ,ij gphpj;J vLj;J Nrfhpj;Jf; 
nfhs;sTk;. gpd;G ,jid xU J}a Jzpapy; ,l;L gpope;njLf;fTk; 
,jw;F thiy ,urk; vd;W ngah;. 
,ypq;fk;:   
gor;rhW> gRk;ghy;> Fg;igNkdpr;rhW> ,k;%d;iwAk; rkvil 
$l;b ,ypq;fj;;jpw;F RUf;fpl;L vLf;f Rj;jpahFk;. 
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tPuk;:   
,sePhpy; rpwpJ #lidf; fye;J xU ghidapy; ,l;L tPuj;ijf; 
Jyhae;jpukhf ePhpy; glhky; miukzp Neuk; vhpj;J vLf;f Rj;jpahFk;. 
G+uk;:   
fk;khW ntw;wpiy> kpsF Mfpa ,uz;ilAk; ¼ gyk; tPjk; vLj;J 
rpwpJ ePh; tpl;L miuj;J fw;fj;ij 1 gb ePhpy; fye;J 1 gyk; G+uj;ij 
rPiyapy; Kbe;J Jyhae;jpukhf ePhpy; mkpOk; gb nra;J rpW jPahy; 
vhpf;fTk;. ePh; 3/4 gq;F Rz;ba gpwF G+uj;ij vLj;J fOtp ntapypy; 
cyh;j;jp vLf;f Rj;jpahFk;. 
fe;jfk;:   
fe;jfj;ij xU ,Uk;G fuz;bapy; ,l;L rpwpJ gR ntz;nza; 
,l;L cUf;fp gRk;ghypy; rha;f;fTk;. ,t;tpjk; 30 Kiw nra;a 
Rj;jpahFk;.  xt;nthU KiwAk; Gjpa ghiy cgNahfpf;f Ntz;Lk;. 
jhsfk;:  
1 gyk; jhsff; fl;b vLj;J Rz;zhk;;Gf; fy;ypd; ,ilapy; 
itj;J gdq;fs;spdhy; gj;J juk; jhspj;J vLj;J fOtp cyh;j;jpf; 
nfhs;s Rj;jpahFk;. 
kNdhrpiy:  
kNdhrpiyf;F vYkpr;rk; gor;rhW tpl;L 1 rhkk; miuj;J 
cyh;j;jp vLj;Jf; nfhs;s Rj;jpahFk;. 
nra;Kiw: 
 ,urk;> fe;jfk; ePq;fyhf kw;w ruf;Ffis fy;tj;jpypl;L; fk;khW 
ntw;wpiyr; rhW njspj;J miuf;fTk;.  fe;jfj;ij jdpahf 
fy;tj;jpypl;L fk;khW ntw;wpiyr; rhW rpwpJ rpwpjhf tpl;L Fok;G 
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gjkhf miuj;J xU rpW FLitapd; cl;Gwj;jpYk; tha;%b mfypd; 
cl;Gwj;jpYk; re;jpy;yhky; G+rp epoypy; cyh;j;jp mjdpy; Kd; miuj;J 
itj;Js;s J}spy; 3/4 ghfkpl;L mOj;jp eLNt gs;sk; nra;J mjdpy; 
thiy ,urk; tpl;L kpFjpAs;s J}is Nghl;L mOj;jp Nky; %b 
kz;rPiy VO nra;J epoypy; cyh;j;jTk;.   
 ,uz;L gb Nrhw;Wg;ig tWj;J mjDld; gj;J gyk; gpuz;ilia 
$l;b ,bj;J gprwp ,it nfhs;s jf;f xU kl;FLitapy; %d;W 
tpuy;fil cauk; Nghl;lOj;jp> rPiy nra;J itj;Js;s rpW FLitia 
eLtpy; itj;J kpFjpAs;s cg;ig NkNy nfhl;b gug;gp mOj;jp  tha;f;F 
XL nfhz;L %b kz;rPiy nra;J cyh;j;jp mLg;gpy; Vw;wp xU rhkk; 
jPghf;fpdpahfTk;> xU rhkk; fkyhf;fpdpahfTk;> ,uz;L rhkk; 
fhlhf;fpdpahfTk; vhpj;J Mwtpl;L ghh;f;f FLitapy; rpte;J cUfp 
,Uf;Fk;.  ,ij miuj;J rPrhtpy; gj;jpug; gLj;jTk;. 
msT> mDghdk;> jPUk; Neha;: 
 gytpj thj Nuhfq;fs;> cl;Fj;J> GwtPr;R> ,tw;wpf;F>  
Rf;F 
  kpsF   #uzj;jpy;> jphpfb gpukhzk; vLj;J> 
  Xkk; 
 KUq;ifg;gl;il rhW $l;b fye;J  
1/2 - 1 Fd;wp (65kp.fp - 130kp.fp) vil nre;J}uk>; ,U Ntis> 20 
ehs; ju FzkhFk;. 
Mjhuk;:  
 gjhh;j;j Fztpsf;fk; - jhJ rPt tFg;G> gf;fk; - 55. 
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PREPARATION OF EXTERNAL MEDICINE 
thjj;jpw;F G+r nehr;rp vz;nza:;  
 ‘nehr;rpr; rhW ehdhop Neujh naz;nz iaAof;F 
   gr;irj; jfuk; ntz;Nfh\;lk; gfUk; Fg;ig naUf;fk;Nth; 
   fr;Rf; fl;L KiyahNs fha;r;rp tbj;J Nky;G+rf; 
   Fj;jpf; FilAk; thjnky;yhk; $$ ntd;W FbGFNk.” 
 jfiu tpij  - 6 tpuhfndil (25.2fp) 
 nts;isf;Nfh\;lk;  - 6 tpuhfndil (25.2fp) 
 rjFg;ig   - 6 tpuhfndil (25.2fp) 
 vUf;fd;Nth;  - 6 tpuhfndil (25.2fp) 
 nehr;rpr;rhW  - 4 gb (8 yp) 
 ey;nyz;nza;  - 5 cof;F (1680 kp.yp) 
nra;Kiw: 
 jfiu tpij> nts;isNfh\;lk;> rjFg;ig> vUf;fk;Nth; ,tw;iw 
,bj;J vLj;Jf; nfhs;sTk;.  nehr;rpr;rhW> ey;nyz;nza; ,tw;Wld; 
Nkw;fz;l nghbia Nrh;j;J vhpj;Jf;nfhz;L> gjj;jpy; ,wf;fp tbfl;bf; 
nfhs;sTk;.   
jPUk; Neha;: 
 typNahL $ba thA> tPf;fj;jpy; G+rTk;. clNd typ epw;Fk;. 
Mjhuk;: 
itj;jpa jpul;L (jQ;rhT+h; ru];tjp k`hy; ntspaPl;L vz; - 184> 
gf;fk; - 4). 
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PROPERTIES OF THE TRIAL DRUG 
I. KIRUBAGARA SHANMUGA CHENDURAM. 
1. ,urk;: 
Synonyms  - Kaaram, Soodham, Punniyam, Karpam,  
   Samam, Sathu, Eesan, Vinnineer,  
   Vinmarunthu, Sukkilam, Gnanam. 
   (Ref: Dhasanga Nigandu) 
Common Name - Quick Silver, Mercury 
Chemical Name - Hydrargyrum 
Suvai   - All the six tastes chiefly of   
  sweet taste  
Veeriyam  - Veppam, Seedha Veeriyam 
Pirivu   - Attains the Pirivu of the adjuvent in  
  which it is administered 
  Action  - Alterative, Tonic, Diuretic,  
  Deobstruent and Sialogogue  
It is the chief metallic element in siddha system of medicine known 
by the name of Sivam, that which takes mankind beyond the reach of 
diseases.  It is appreciated well as the emperor of all the drugs in siddha 
system.  As this includes the tri duty of the omni-potent, in rejuvenating 
the body, it is almost kept in line with HIM. 
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Gunam: 
‘rpttpe;jh kpurQ; nra;AQ; nra;aew; Fzq;fs; nrg;gpy; 
……………………………………………………………”!
 ‘ngUNuhf Nkfq; fhrk; gpsit fhkhiy #iy 
 RukNfh juq;fp ue;jp nrhy;typ thjq; Fd;kk; 
 khpKwp fpue;jp ghz;L khh;gilg;G Nahdpg;Gw;W.” 
! ! ! ! - gjhh;j;j #lhkzp ghly; vz; 287> 288. 
 ,urj;jhy; Nkfk;> fhrk;> gpsit> fhkhiy> #iy> kNfhjuk;> Ruk;> 
fpue;jp> thjNeha;fs;> typ> Fd;kk;> ghz;L> khh;gilg;G> NahdpGw;W 
Kjypa Neha;fs; jPUk;.  
2. ,ypq;fk;: 
Synonyms  :  Inguligam, Kadaivanni karpam,  
      Sandagam, Samarasam, Maniraagam,  
            Vanni, Aankuri. 
Common Name : Cinnabar  
Chemical Name : Red sulphide of Mercury 
Veeriyam  : Veppam 
Action  : Alterative 
Gunam: 
‘rhjpypq; fj;jpd; wd;ik rhw;wpbw; FzNk ahjp 
   #jNu uhFq; Fl;lQ; #iyjPf; Fd;kq; Fj;J 
   thjNk typ Ruq;fs; tsh;rd;dp ghz;L thA 
   XjpLq; Nfhio aPio Aiu jU kpitNa ahjp.” 
. gjhh;j;j Fz #lhkzp ghly; vz;. 291 
,ypq;fk; Fl;lk;> #iy> Fd;kk;> thjk;> typ> Ruk;> rd;dp> ghz;L 
Kjypa gpzpfis ePf;Fk;. 
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3. G+uk;: 
Synonyms   - Rasakarpooram 
Chemical Name - Hydragyrum subchloride  
Suvai   - Salt and Acrid 
Veeriyam  - Veppam 
Pirivu   - Acrid  
Action  - Alterative, Sialogogue, Antiseptic 
Gunam: 
 ‘,ilthj #iy nahp#iy Fd;ke; 
    njhilthio thjkhQ; Nrhzp-apilahNjh 
  nthf;Fur fh;g;G+u nkhd;Nw asnthLey; 
  ,f;Fnty;yj; NjOeh sP.” 
. Fzg;ghlk; jhJrPtk;> gf;fk; - 210  
ey;y ,ur fh;g;G+uj;ij msTld; fUk;G nty;yj;jpy; VOehs; 
nfhLf;f ,Lg;ig gw;wpa #iy> vhpr;riy jUfpd;w #iy> thj Fd;kk;> 
njhil thio> thj ,uj;j Neha; Kjypad jPUk;;. 
4. tPuk;: 
Synonyms   - Meenakshi myndhan, Saarathin sathru,  
  Parimithru, Sarakuchunnam,  
   Cochiveeran 
Chemical Name - Hydrargyrum perchloride 
Suvai   - Acrid and salt 
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Veeriyam  - Veppam 
Pirivu   - Acrid  
Action  - Alterative, Antiseptic, Disinfectant,  
  Caustic. 
Gunam: 
 ‘Rukz;l thA rd;dp njhlh;typ Fku fz;ld; 
   tUtp\q; fz;l khiy thjk;tpw; GUjp Nfhio 
  ciungU Neha;f ug;gDl; Fj;Jg; GwtPr; rPio 
  rUtpa fpue;jp Fl;lQ;  rt;tPue; njhiyf;F khNk.” 
. gjhh;j;j #lhkzp> ghly;  vz;- 299 
Ruk;> mz;lthA> rd;dp> Fkufz;ltyp> fz;lkhiy> thjk;> 
njhlh;typ> fug;ghd;> cl;Fj;J> GwtPr;R> fpue;jp> Fl;lk; Kjypa 
Neha;fis ePf;Fk;. 
5. fe;jfk;: 
Synonyms  - Kaarilaiyin naadham, Sakthi,  
                                 Sendoorathathi, Deviuram, Ponvarni,  
                                 Rasasuronitham. 
Common Name - Brim stone 
Chemical Name - Sulphur 
Action  - Cholagogue, Laxative, Alterative,  
    Antiseptic, Diaphoretic 
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¾ Gandakam is of four types according to its colour viz, White, Red, 
Golden and Black colour. 
¾ The sulphur which is golden colour (Nellikai Gandakam) is used as 
medicine. 
Gunam: 
 ‘ney;ypf;fha; nfe;j fj;jp ndwpNfsha; fTrp Fd;kk; 
  ty;yjhk; thA Fl;lk; typtplq; fLq;fp ue;jp 
  nrhy;ypLQ; Ruq;f nsy;yhe; njhiye;jpL nkd;W Kd;dh; 
  gy;tif Kdpth; rpj;jh; gfh;e;jth flq;fs; nrhy;Yk;.” 
. gjhh;j;j #lhkzp ghly; vz; - 298 
Fd;kk;> thA> Fl;lk;> fpue;jp> Ruk;> typ Kjypad ney;ypf;fha;  
fe;jpahy; jPUk;. 
6. kNdhrpiy: 
Synonyms   - Silai, Vil, Kunadi, Naan mugan, Devi,  
     Thamarai-vasini, Sarasothi 
   Common Name - Red orpiment, Realgar 
  Chemical Name -  Bisulphuret of arsenic 
  Action  - Alterative, Febrifuge, Nutrient 
Gunam: 
 ‘Gfd;kNdh rpiyapd; ed;ik nghy;yhj rd;dp thA 
  ,fyhd RuNk thj kpitjik ePf;F nkd;g.” 
. gjhh;j;j #lhkzp ghly; vz; - 294. 
rd;dp> thA> Ruk;> thjk;;> Kjypad kNdhrpiyahy; jPUk;. 
 
125
7. jhsfk;: 
Synonyms  - Peethagi, Aalambi, Maalam,  
  Aridharam, Ponvarni, Maaldevi. 
  Common Name - Yellow orpiment 
  Chemical Name - Tri sulphuret of arsenic 
  Action  - Febrifuge, Alterative, Nutrient,  
  Emetic, Expectorant, Antidote. 
Gunam: 
 ‘jhsfe; jhNd ay;y jhpjhu kjd;F zq;Nfs; 
  Nfhs;nrAq; Fd;k ky;yhw; nfhLkO fz;zp rd;dp 
    ehSNk tUe;Jfpd;w kz;ilNeha; espuhh; fha;r;ry; 
  khSnkd; Wiuj;jhh; Kd;Nd thUjp Az;l NkNyhh.;” 
. gjhh;j;j #lhkzp ghly; vz; - 295 
jhsfj;jhy; Fd;kk;> mOfz;zp> rd;dp> kz;ilNeha;> fha;r;ry; 
Kjypad jPUk;. 
Jiz kUe;J: 
1. Rf;F: 
English Name - Dried Ginger 
Botanical Name - Zingiber officinale 
Family  - Zingiberaceae 
Part used  - Dried and scraped rhizome 
Suvai   - Acrid 
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Thanmai   - Veppam  
Pirivu   - Kaarppu 
Constituents  - Camphene, Phellandrene, Zingiberine,  
  Cineol, Borneol, Gingerol, Oleo resin –  
  Gingerin, the active principle. 
  Action  - Stimulant, Stomachic, Carminative 
Gunam: 
 ‘Nfs;Rf;fpd; Fzj;ijr; #iy nfhLfgk; thj tPf;fk; 
 ……………………………………………………………………  
 %s;typ %d;W Njh\k; Kr;Rue; jiyNeh apd;Dk;”. 
. gjhh;j;j #lhkzp ghly; vz; - 277 
Rf;fpdhy; #iy> fgk;> thjtPf;fk;> ePh;f;Nfhit> ke;jk;> Fd;kk;> 
,Uky;> Rthrfhrk;> Njhlk; Kjypad ePq;Fk;. 
2. kpsF: 
English Name - Black pepper  
Botanical Name - Piper nigrum 
Family  - Piperaceae 
Part used  - Dried unripe fruit 
Suvai   - Bitter, acrid 
Thanmai  - Veppam 
Pirivu   - Acrid 
Constituents  - Piperine, piperidine, chavicin, a soluble  
pungent resin.  Piperine possess mild 
anti pyretic and antiperiodic action. 
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Action  - Acrid, Carminative, Antiperiodic,  
             Resolvent, Rubefacient, Stimulant,  
             Antivatha, Antidote. 
Gunam: 
 ‘thjk; mUrpgpj;jk; kh%yk; XJrd;dp 
  ahrkg]; khuk; mld;Nkfk; fhrkpit 
  ehrq; fwpkpsfpdhy;.” 
- gjhh;j;j #lhkzp. 
  kpsfpdhy; ghz;L> fgk;> fpuhzp> Fd;kk;> thjNeha;fs;> 
gpj;jk;> %yk;> rd;dp> mg];khuk;> Nkfk;> fhrk;> Kjypad ePq;Fk;. 
3. Xkk;: 
English Name - Bishops weed 
Botanical Name - Carum copticum, Benth 
Family  - Umbelliferae 
Part used  - Seeds  
Constituents  - Essential oil, thymol 
Action  - Stomachic, Antispasmodic,            
  Carminative, Antiseptic, Stimulant,  
   Tonic, Sialogogue. 
Gunam: 
 ‘Xkk; $wUk; typNa thA 
  fiwAw;w tpiur;rd; ke;jq; fopr;rY khw;W nkd;g” 
! ! !         - gjhh;j;j #lhkzp> ghly; vz; - 240   
,jdhy; typ> thA> ,iug;G> ke;jk;> fopr;ry; FzkhFk;. 
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mDghdk;: 
1. KUq;ifg;gl;il 
Botanical Name - Moringa oleifera 
Family  - Moringaceae 
Part used  - Stem bark 
Suvai   - Bitter, Astringent, Sweet. 
Thanmai  - Thatpam 
Pirivu   - Acrid 
Constituents  - 4-benzylisothiocyanate alkaloid,  
  Resin 
Gunam: 
 ‘tha;nthLtp lq;fSNkw;  
  gl;ilf;Fg; NghNk gwe;J” 
. Fz ghlk; - %ypif> gf;fk; - 773 
KUq;if kug;gl;ilapdhy; tspf;Fw;wKk;> rpy eQ;RfSk; ePq;Fk;. 
II. VATHATHIRKU POOSA NOCHI ENNEI  
1. nehr;rp: 
Botanical Name - Vitex negundo 
Family  - Verbenaceae 
Part used  - Leaves  
Suvai   - Bitter, Astringent, Acrid 
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Thanmai  - Veppam 
Pirivu   - Acrid 
Constituents  - Essential oil, resin  
Action  - Leaves are externally Anti – parasitic.  
Gunam: 
 ‘te;jKjy; ez;ghfp thjj;ij NaAwthw; 
  rpe;Jth uq;fdYe; jP” 
. Fzghlk; %ypif gf;fk; - 628 
nehr;rpapiy tspf;Fw;wj;ij jd;dpiyapy; epw;f nra;Ak;. 
Leaves are very efficacious in dispelling inflammatory swellings of  
joints from acute rheumatism. 
2. nts;is Nfh\;lk;: 
Botanical Name - Costus speciosus 
Family  - Scitaminaceae 
Part used  - Root and tuber 
Suvai   - Bitter 
Thanmai  - Veppam 
Pirivu   - Acrid 
Constituents  -  β-sitosterol, β-glucoside,gracillin 
Action  - Stomachic, Expectorant, Tonic,  
                                  Stimulant, Diaphoretic. 
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Gunam: 
 ‘jsh;tpyhf; Nfhl;lq; fz;Nzha; raq;fhr Rthrk; thjk; 
  mstpyhr; Ruq;fs; the;jp aUkPio tpf;fy; khw;Wk;” 
. gjhh;j;j #lhkzp> ghly; - 245. 
Nfh\;lk; - Rthrfhrk;> fz;Nzha;> thjk;> Ruk;> the;jp 
Kjypatw;iw Nghf;Fk;. 
3. vUf;F : 
Botanical Name - Calotropis gigantea 
Family  - Asclepiadaceae 
Part used  - Root  
Suvai   - Bitter, acrid, sweet 
Thanmai  - Veppam 
Pirivu   - Acrid 
Constituents  - Cautchoue, yellow bitter resin,  
  Calotropin, giganteol. 
Action  - Alterative, Febrifuge, Stimulant, Tonic,  
                                 Diaphoretic, Emetic. 
It is known as vegetable mercury and is used in chronic 
rheumatism. 
Gunam: 
 ‘kd;didAq; ifnaLf;f itj;njapw;wp Ndafw;wp 
  Ad;D gpzpg;gzpia Nahl;Ljyhw; nrhd;Ndd;” 
. Fz ghlk; - %ypif> gf;fk; - 153 
vUf;F thjNeha;fSf;F ed;kUe;jhFk;> gy Neha;fisAk; 
Nghf;Fk;. 
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4. jfiu tpij: 
Botanical Name - Cassia tora 
Family  - Caesalpiniaceae 
Part used  - Seeds 
Suvai   - Bitter, salt 
Thanmai  - Veppam 
Pirivu   - Acrid 
Constituents  - Glucoside resembling chrysophanic  
  acid.  Seeds contains emodin allied to     
  chrysophanic acid in characteristics. 
  Action  - Externally Germicide, Antiparasitic  
5. rjFg;ig: 
Botanical Name - Anethum sowa  
Family  - Umblelliferae 
Part used  - Seeds 
Suvai   - Sweet, acrid 
Thanmai  - Veppam 
Pirivu   - Acrid 
Constituents  - Contains volatile oil, fixed oil. The  
                                 volatile oil contains anethine,  
                                 phellandrene, d-limonene, apiol, carvol. 
Action  - Carminative, Stomachic, Aromatic,  
                                  Stimulant, Diuretic, Resolvent,  
                                  Emmenegogue, Galactogogue. 
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 The seeds are bruised and boiled in water and are applied 
externally in rheumatic and other swelling of joints. 
Gunam: 
 ‘thjnkhL #jpfh thjk; rpuRNeha; 
 ………………………………………. 
 Qhyr; rjFg;ig ehL.” 
. Fz ghlk; - %ypif> gf;fk; - 422 
rjFg;ig tspNeha;> jiytyp> fhJtyp Kjypatw;iw ePf;Fk;. 
6. ey;nyz;nza; : 
Botanical Name - Sesamum indicum  
Family  - Pedaliaceae 
Parts used  - Seeds 
Suvai   - Sweat 
Thanmai  - Veppam 
Pirivu   - Sweat 
Constituents  - Oil contains 70pc of liquid fats  
  consisting of the glycerides of oleic,     
   linoleic acids and 12-14pc of solid fats,    
   stearin, palmitin and myristin,  
   crystalline substance sesamin and sesamol. 
Action  - Seeds are Laxative, Emollient and  
                                 Demulcent, Diuretic, Nutritive. 
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Gunam: 
 ‘,t;ntz;iz fhe;jp gpj;j kpisg;GNej; jpuj;jpd; Nuhfk; 
  ft;itNrh; rput ypg;Gf; fghyKl; lzQ;rp uq;Nfh 
  nlt;tkhh; fpUkp Nghf;F nkop Yq;fz; nzhspA Kz;lhk; 
  nrt;itahk; ngyD Kz;lh nkd;dNt nrg;gp dhNu” 
. gjhh;j;j #lhkzp> ghly; - 33 
vs;nea;ahy; gpj;j Neha;fs;> ,isg;G> fz;Neha;fs;> jiytyp  
Kjypad ePq;Fk;. fhe;jp> fz;xsp cz;lhFk;. 
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ANNEXURE II 
BIO – CHEMICAL ANALYSIS OF 
KIRUBAGARA SHANMUGA CHENDURAM 
PREPARATION OF THE EXTRACT:  
 100mg Of Chenduram was weighed accurately and was placed in a 
clean beaker. Then a few drops of conc. Hydrochloric acid is added and 
evaporated it well. After evaporation the contents were cooled and a few 
drops of concentrated Nitric acid is added and evaporated well. After 
cooling the contents, 20 ml of distilled water was added and dissolved 
well. Then it was transferred to 100 ml volumetric flask and made up to 
100ml with distilled water. The mixture was mixed well and filtered. 
Then it was taken for analysis.  
 
Qualitative Analysis 
S.no Experiment Observation Inference 
1. TEST FOR CALCIUM 
2ml of the above prepared extract is 
taken in a clean test tube.  2 ml of 4% 
Ammonium Oxalate solution is added 
to it. 
A white 
precipitate is 
formed. 
Indicates the 
presence of 
Calcium. 
 
135
2. TEST FOR SULPHATE 
2ml of the extract is added to 5% 
Barium Chloride solution. 
White 
precipitate is 
formed. 
Indicates the 
presence of 
Sulphate. 
3. TEST FOR CHLORIDE 
The extract is treated with Silver 
Nitrate solution. 
A white 
precipitate is 
formed. 
Indicates the 
presence of 
Chloride. 
4. TEST FOR CARBONATE 
The substance is treated with 
Concentrated HCl. 
No brisk 
effervescence 
is formed. 
Absence of 
Carbonate. 
5. TEST FOR ZINC 
The extract is added with Potassium 
Ferro Cyanide solution. 
No white 
precipitate is 
formed 
Absence of 
Zinc 
6. TEST FOR IRON- FERRIC  
The extract is treated with Glacial 
Acetic Acid and Potassium Ferro 
Cyanide.                    
No blue 
colour is 
formed. 
Absence of 
Ferric Iron. 
7. TEST OF IRON - FERROUS 
The extract is treated with 
concentrated Nitric Acid and 
Ammonium Thio Cyanate. 
Blood red 
colour is 
formed. 
Indicates the 
presence of 
Ferrous  Iron.
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8. TEST FOR PHOSPHATE 
The extract is treated with Ammonium 
Molybdate and concentrated Nitric 
Acid. 
No Yellow 
precipitate is 
formed. 
Absence of 
Phosphate. 
9. TEST FOR ALBUMIN  
The extract is treated with Ferric 
Chloride 
No yellow 
precipitate is 
formed. 
Absence of 
Albumin. 
10. TEST FOR TANNIC ACID 
The extract is treated with Esbach’s 
reagent 
No blue 
black 
precipitate is 
formed. 
Absence of 
Tannic Acid. 
11. TEST FOR UNSATURATION 
To the extract Potassium 
Permanganate solution is added. 
It gets 
decolourised. 
Indicates the 
Presence of 
Unsaturated 
Compound. 
12. TEST FOR THE REDUCING 
SUGAR 
5ml of Benedict’s qualitative solution 
is taken in a test tube and allowed to 
boil for 2 mts.  Add 8-10 drops of the 
extract and again boil it for 2 mts. 
No colour 
change 
occurs. 
Absence of 
Reducing 
Sugar. 
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13. TEST FOR AMINO ACID: 
One or two drops of the extract is 
placed on a filter paper and dried well. 
After drying, 1% Ninhydrin is sprayed 
over the same and dried well. 
No Violet 
colour is 
formed. 
Absence of 
Amino Acid 
14. TEST FOR MERCURY: 
The extract is treated with Ammonia 
and boiled (till the ammonia caeses 
off) and then Potassium Iodide is (1% 
solution) added 
A scarlet 
Precipitate 
Is formed 
It indicates 
the presence 
of Mercury 
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ANNEXURE III 
PHARMACOLOGICAL ANALYSIS 
ANALGESIC STUDY ON KIRUBAGARA SHANMUGA 
CHENDURAM 
(In Albino rats by Hot Water Bath Method) 
Aim: 
 To study the analgesic effect of Kirubagara Shanmuga Chenduram. 
Preparation of the test medicine: 
 200mg of kirubagara shanmuga chenduram was taken.  It was 
mixed with 1g of chukku, milagu and omam choornam and dissolved in 
10ml of murungai pattai juice extract.  A dose of 1ml was given to each 
rat. This 1ml contains 20mg of test medicine. 
Procedure: 
 Three groups of healthy albino rats of both sexes were selected, 
each group having 3 rats, weighing between 100 to 150gm.  The hot 
water bath was maintained at a temperature of 55°C. 
 The tail was dipped into the bath, and the time taken for each rat to 
remove its tail from the hot water bath was noted.  The rat which took 
more than 5sec for removal of its tail from hot water bath was excluded 
from the experiment. 
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 First group was kept as control by giving distilled water of 2ml per 
100mg of body weight. 
To the Second group  paracetamol 20mg per 100gm of body 
weight  was given and  was kept as standard. 
To the third group test medicine was given. 
 30 minutes after the administration of medicines, the tail of each rat 
was dipped into hot water bath one by one.  The time taken for each rat to 
remove its tail was noted.  The whole experiment was repeated after 30 
minutes. 
 The results of control, standard and test medicine groups were 
tabulated and compared. 
Study of Analgesic Action by Hot water bath method using 
Kirubagra Shanmuga Chenduram. 
Serial 
No. 
Name of Drug / 
Groups 
Dose /100 
gram body 
weight 
Initial 
Reading 
(Seconds)
After Drug 
administration 
½ hr. 
(Average) 
1 hr. 
(Average) 
1 Control 2ml 2.1 2.5 2.5 
2 Ibuprofen 20mg 2 5.5 6.7 
3 Kirubagara 
Shanmuga 
Chenduram 
 
20mg 
 
2.1 
 
3 
 
4.85 
Inference: 
 It is observed that Kirubagara Shanmuga Chenduram has got 
Significant Analgesic Action. 
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ANTI-PYRETIC STUDY ON KIRUBAGARA 
SHANMUGA CHENDURAM 
(By Yeast induced Method) 
Aim: 
 To study the anti-pyretic activity of the Kirubagara Shanmuga 
Chenduram. 
Procedure: 
 Three groups of healthy albino rats were taken, each weighing 
about 100-200gm, each group consisting of 2 rats. All the rats were made 
hyperthermic by subcutaneous injection of 12% suspension of Yeast at a 
dose of 100ml/100mg body weight. 
 10 hrs later one group of rats were given the test drug Kirubagara 
Shanmuga Chenduram with Chukku, Milagu, Omam Choornam and 
Murungai Pattai Chaaru at a dose of 1 ml consisting of 20 mg/100 gm of 
body weight. The other group received distilled water at a dose of 1 
ml/100 gm of body weight and kept as control. The last group was given 
Paracetamol at a dose of 20 mg/ 100 gm body weight and kept as 
standard. 
 The mean rectal temperature for 3 groups was recorded at 0 hr,    
1½ hrs, 3 hrs and 4 ½ hrs after the drug administration. The difference in 
mean temperature between the 3 groups were noted and compared. 
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Study of Anti-Pyretic Action by Yeast Induced Method using the 
drug, Kirubagara Shanmuga Chenduram  
Sl 
No. 
Name of 
Drug / 
Groups 
Dose / 
100 
gram 
body 
weight 
Initial 
Temperature 
in centigrade 
After Drug administration 
Mean 
temperature
1 ½ hr 3.0hr 4 ½ hr 
1. Control 2ml 
36.0 
37.0 
36.0 
37.0 
36.0 
38.0 
37.0 
39.0 
38.0 
2. Standard 
(paracetamol) 
20mg 
37.0 
38.0 
37.0 
37.0 
36.5 
36.5 
35.0 
34.0 
34.5 
3. Kirubagara 
Shanmuga 
Chenduram 
20mg 
37.5 
37.5 
37.0 
37.5 
36.5 
37.0 
36.5 
36.5 
36.5 
 
Inference - The test drug Kirubagara Shanmuga Chenduram has 
Significant Anti-Pyretic Action. 
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ACUTE ANTI-INFLAMMATORY STUDY ON 
KIRUBAGARA SHANMUGA CHENDURAM 
(By Hind paw Method in Albino Rats) 
Aim: 
 To study the Acute Anti-inflammatory effect of Kirubagara 
Shanmuga Chenduram. 
Preparation of the test medicine: 
 200mg of kirubagara shanmuga chenduram was taken.  It was 
mixed with 1g of chukku, milagu and omam choornam and dissolved in 
10ml of murungai pattai juice extract.  A dose of 1ml was given to each 
rat. This 1ml contains 20mg of test medicine. 
Procedure: 
 Nine healthy albino rats weighing 100 – 150 gm were taken and 
divided into three groups, each consisting of 3 rats. 
 First group was kept as control by giving distilled water of             
2ml / 100gm of body weight.  The second group was given Ibuprofen at 
dose of 20mg / 100gm of body weight.  The third group received the trial 
medicine, Kirubagara Shanmuga Chenduram at a dose of 20mg / 100gm 
of body weight. 
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 Before the administration of trial medicine, the hind – paw volume 
of all the rats were measured.  This was done by dipping the hind paw up 
to tibio tarsal junction, into a mercury plethysmograph.  While dipping 
the hind paw, pull the syringe piston so that the level of mercury in the 
center small tube was made to coincide with the red marking and the 
reading was noted from the plethysmograph. 
 Soon after the measurement, the medicines were administered 
orally.  One hour later, a subcutaneous injection of 0.1ml of 1% (w / v) 
carrageenin in water was made into the plantar surface of both hind paw 
of each rat. 
 Three hours after carrageenin injection, the hind paw volume was 
measured once again.  The difference between the initial and final volume 
was calculated and compared. 
 The method is more suitable for studying the Anti – inflammatory 
activity in acute inflammation.  The values are given in the table. 
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Study of Acute Anti–inflammatory effect by Hind-paw method using 
Kirubagara Shanmuga Chenduram: 
Serial 
No. 
Name of 
Drug/ 
Groups 
Dose 
/100 
gram 
body 
weight 
Initial 
Reading 
average 
Final 
reading 
average
Mean 
difference
Inflammation 
(Percentage) 
Inhibition 
(Percentage)
1 Control 2ml 0.55 1.4 0.85 100 Nil 
2 Ibuprofen 20mg 0.55 0.85 0.3 35.2 64.8 
3 Kirubagara 
Shanmuga 
Chenduram 
 
20ml 
 
0.5 
 
0.75 
 
0.25 
 
29.4 
 
71.6 
 
Inference: 
 It is observed that Kirubagara Shanmuga Chenduram has got 
Significant Acute Anti-inflammatory Action. 
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CHRONIC ANTI-INFLAMMATORY STUDY ON 
KIRUBAGARA SHANMUGA CHENDURAM 
(Cotton pellet Granuloma Method) 
Aim: 
 To study the chronic anti-inflammatory activity of Kirubagara 
Shanmuga Chenduram in rats by cotton pellet implantation (Granuloma) 
method. 
Preparation of the test medicine: 
 200mg of kirubagara shanmuga chenduram was taken.  It was 
mixed with 1g of chukku, milagu and omam choornam and dissolved in 
10ml of murungai pattai juice extract.  A dose of 1ml was given to each 
rat. This 1ml contains 20mg of test medicine. 
Procedure: 
 Cotton pellets each weighing 10mg was taken and sterilized in an 
autoclave for about one hour under 15 pounds atmospheric pressure.  9 
albino rats weighing between 150 to 200mg were selected and were 
divided into 3 groups each containing 3 rats.  Each rat was anaesthetized 
with ether and cotton pellets were implanted subcutaneously into the 
groin, two on each side. 
 From the day of implantation, one group of animals received 
Kirubagara Shanmuga Chenduram at a dose of 20mg / 100gm of body 
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weight.  The standard group of animals received Ibuprofen at a dose of 
20mg / 100gm body weight.  The control group of animals received 2ml 
of distilled water. 
 On the eighth day the rats were sacrificed and the pellets were 
removed and weighed.   Then they were put in an incubator at             
60°C - 80°C and then the weight of the granulation tissue was determined 
separately. 
Study of Chronic Anti-inflammatory effect by cotton pellet method 
using Kirubagara Shanmuga Chenduram. 
Sl 
No. 
Name of 
Drug/ 
Groups 
Dose 
/100 
gram 
body 
weight 
Pellet 
weight
Pellet 
weight of 
the 
Granuloma 
of drugs 
Mean 
difference
Inflammation 
(Percentage) 
Inhibition 
(Percentage)
1 Control 2ml 10mg 250mg - 100 Nil 
2 Ibuprofen 20mg 10mg 56mg - 22.4 77.6 
3 Kirubagara 
Shanmuga 
Chenduram 
 
20mg 
 
10mg 
 
130mg 
 
- 
 
52 
 
48 
 
Inference: 
 It is observed that Kirubagara Shanmuga Chenduram has 
Significant Chronic Anti-inflammatory action. 
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ACUTE ANTI-INFLAMMATORY STUDY ON 
VATHATHIRKKU POOSA NOCHI ENNEI 
(By Hind-paw Method in Albino Rats) 
Aim: 
 To study the acute anti-inflammatory study on Vathathirkku Poosa 
Nochi Ennei by hind paw method in albino rats. 
Procedure: 
 Six albino rats weighing between 100 – 150 gm were selected and 
divided into two groups each containing three rats.  To the first group 
distilled water was given and kept as a control.   Before the application of 
the trial medicine, the hind paw volume of all the rats were measured.  
This was done by dipping the hind-paw up to the tibio-tarsal junction in 
mercury plethysmograph. 
 Subcutaneous injection of 0.1 ml of 1% carrogenin (w/v) in water 
was made into plantar surface of both the hind paw of each rat.  To the 
test group, Nochi ennei was applied topically and frequently over the 
inflammed surface in a thin layer.  To the control group, no drug was 
applied over the inflammed surface.  One and half an hour after injection, 
the hind paw volume was measured once again.  The difference between 
the initial and final volume shows the amount of inflammation.  Taking 
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the volume in the control group as 100% of inflammation, the              
anti-inflammatory effect of the group is calculated. 
Study of Acute Anti-Inflammatory effect by Hind paw Method using 
Vathathirkku Poosa Nochi Ennei. 
Sl 
No. 
Name of 
Drug/ 
Groups 
Dose 
/100 
gram 
body 
weight 
Initial 
Reading 
average 
Final 
reading 
average
Mean 
difference
Inflammation 
(Percentage) 
Inhibition 
(Percentage)
1 Control 2ml 0.55 1.4 0.85 100 Nil 
2 Ibuprofen 20mg 0.55 0.85 0.3 35.2 64.8 
3 Vathathirkku 
Poosa Nochi 
Ennei 
 
External 
 
0.45 
 
0.75 
 
0.3 
 
35.2 
 
64.8 
 
Inference: 
 From the above experiment it is concluded that Vathathirkku Poosa 
Nochi Ennei has got Significant Acute Anti-inflammatory Action. 
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ANNEXURE - IV 
ACUTE TOXICITY STUDY 
Animals: 
Wistar albino rats bred in the animal house attached to the Post 
Graduate, Pharmacology Department, Govt. Siddha Medical College, 
Palayamkottai were used. 
Sex: 
¾ Animals of both sexes were used. 
Weight: 
¾ Animals weighing between 80 – 120 gm were selected. 
Food and water: 
¾ The animals were maintained with standard animal feed and water 
ad-libitum. 
Number of animals: 
10 rats were divided into 5 groups, each group consisting of 2 rats. 
Dose levels: 
The following dose levels were arbitrarily fixed by presuming 
range of least toxic to high toxic doses. 
I Group                  100mg/100gm body weight of animal 
II Group                200mg/100gm body weight of animal 
III Group              400mg/100gm body weight of animal 
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IV Group              800mg/100gm body weight of animal 
V Group               1600mg/100gm body weight of animal 
Route of administration: 
Oral administration. 
Preparation of the test drug for administration: 
The drug was weighed and taken.  Then it was suspended in a 
solution containing Chukku, Milagu and Omam Choornam and Murungai 
Pattai Juice extract.  The mixture was ground well before administration.  
The preparation was done in such a way so that 1ml of suspension 
contains 100mg of Kirubagara Shanmuga Chenduram. The drug was 
administered in the morning and was observed. 
OBSERVATIONS: 
The following details are recorded 
1. Stimulation: 
¾ Hyper activity 
¾ Piloerection 
¾ Twitching 
¾ Rigidity 
¾ Irritability 
¾ Jumping 
¾ Clonic convulsion 
¾ Tonic convulsion. 
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2. Depression 
¾ Ptosis 
¾ Sedation 
¾ Sleep 
¾ Loss of Pinna Reflex 
¾ Ataxia 
¾ Loss of muscle tone 
¾ Analgesia 
3. Autonomic effects: 
¾ Straub tail 
¾ Laboured respiration 
¾ Cyanosis 
¾ Blanching 
¾ Reddening 
¾ Abnormal Secretion 
At the end of 24 hours, the number of animals live or dead in each 
group was noted.  The animals were morphologically examined for any 
adverse reactions.  Individual weight of the animals were examined 
before and after administration of the drug. 
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RESULT: 
 The said parameters in acute toxicity study were observed on five 
groups (Group-I, Group-II, Group-III, Group-IV, Group-V). Group I to V 
were treated with the drug such as, 100mg, 200mg, 400mg, 800 mg, 
1600mg/100 g body weight of the animal respectively. 
 From the observation of the animals, it is being found that the drug 
“Kirubagara Shanmuga Chenduram” did not produce any stimulation, 
depression, autonomic effects nor does it produce mortality even up to 
1600 mg/100 g body weight of the animal. 
So, it is inferred that the drug is found to be safe up to 1600 
mg/100g body weight of the animal. 
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ANNEXURE IV 
Case -Sheet Proforma for “UDHIRA VATHA SURONITHAM” 
P.G. POTHU MARUTHUVAM DEPARTMENT 
GOVT. SIDDHA MEDICAL COLLEGE, PALAYAMKOTTAI. 
Ward  :    Nationality  : 
I. P. No :    Religion  : 
Bed. No :    Date of Admission : 
Name  :      
Age (Years) :   
 
     Date of Discharge :  
Gender :   M F    Result   : 
Occupation :    Diagnosis  : 
Income :    Medical officer : 
Address : ………………................ 
    ………………………… 
    …………………………              
Complaints & Duration:  
 …………………………………………………………………………………
…………………………………………………………………..………………………
………………………………………………………………………………………….. 
History of  Present illness: 
 …………………………………………………………………………………
…………………………………………………………………..………………………
…………………………………………………………………………………………. 
Past history: ……………………………………………………………………… 
 
Family History :     Yes    No 
             
         If any : …………..…………………………… 
Social Status:  low  Middle    Upper      
 
Habits:   Yes  No 
Smoker   :    _______________ 
Alcoholic  :    _______________ 
Tobacco chewer :    _______________ 
Betel nut chewer :    _______________ 
Food habits  :       V          M  _______________ 
GENERAL EXAMINATION: 
Consciousness   : 
Nourishment   : 
Body temperature(0F)  :    
Blood pressure (mmHg) :    
Pulse rate/min   :  
Respiratory rate/min  :  
Yes   No 
Anaemia       _______________  
Jaundice       _______________ 
Cyanosis       _______________  
Clubbing       _______________ 
Pedal oedema       _______________ 
Generalised lymphadenopathy    _______________ 
Engorged veins      _______________ 
JVP        _______________ 
 
IN SIDDHA ASPECTS 
NILAM:  
   Kurinji                  Mullai       Marutham    
    Neithal            Paalai       
KAALA  IYALBU: 
Kaarkaalam                  KoothirKaalam                  Munpani         
Pinpani                         Ilavenir                              Mudhuvenir       
IYMPORIGAL / IYMPULANGAL: 
   1. Normal  2. Affected 
Mei           _______________ 
Vaai           _______________ 
Kan           _______________ 
Mookku          _______________ 
Sevi                                     _______________ 
KANMENTHIRIYANGAL / KANMAVIDAYANGAL: 
      Normal Affected 
 Kai        _______________ 
Kaal           _______________ 
Vaai           _______________ 
Eruvaai          _______________ 
Karuvaai          _____________ 
 
UYIR THATHUKKAL: 
I. Vali: 
Normal Affected 
Praanan         _______________ 
Abaanan         _______________ 
Viyanan          _______________ 
Udhaanan           _______________ 
Samaanan              ______________ 
Naagan          _______________ 
Koorman         _______________ 
Kirukaran         _______________ 
Devathathan           _______________ 
Dhananjeyan            _______________ 
 
II. Azhal:                                                                                                                               
      Normal  Affected 
Anal pitham       ______________ 
Prasaga pitham      _______________ 
Ranjaga pitham      _______________ 
Aalosaga pitham      _______________ 
Saathaga pitham      _______________ 
 
III. Iyam: 
       Normal   Affected 
Avalambagam       _______________ 
Kilethagam       _______________ 
Pothagam       _______________ 
Tharpagam       _______________ 
 Santhigam       _______________ 
UDAL THATHUKKAL: 
                Normal Affected 
Saaram       _______________ 
Senneer                  _______________ 
Oon        _______________ 
Kozhuppu                  _______________ 
Enbu        _______________ 
Moolai        _______________ 
Suronitham/ Sukkilam     _______________ 
ENNVAGAI  THERVUGAL: 
Naa    : _______________________________ 
Niram    : _______________________________  
Mozhi    : _______________________________ 
Vizhi    : _______________________________ 
Naadi    : _______________________________ 
Sparisam   : _______________________________ 
Malam    : _______________________________ 
 
 
 
Moothiram   :  
 Neerkuri   
                        Niram  : _______________  
  Edai  : _______________    
Manam : _______________  
  Nurai  : _______________ 
  Enjal  : _______________ 
 Nei kuri  : _______________ 
IN MODERN ASPECTS 
SYSTEMIC EXAMINATION 
Inspection: 
Skin over the Joints : Normal   Reddish  
Joint Swelling  :  Yes    No   
 MCP, PIP : Yes    No   
 Wrist Joint : Yes    No   
 Elbow Joint : Yes    No   
 Shoulder Joint : Yes    No   
 Knee Joint : Yes    No   
 Ankle Joint : Yes    No   
 MTP Joint : Yes    No   
 Cervical Spine :  Yes    No   
Muscle Wasting : Yes     No   
Deformities:     Yes     No 
Swan neck deformity          
Button hole deformity         
Ulnar deviation of the Hand        
Foot deformity          
 
 
Palpation: 
   Present          Absent 
Local Temperature         
Tenderness           
Evidence of intra articular fluid        
Local lymphadenopathy         
Subcutaneous nodules         
Rheumatoid vasculitis lesions       
Pitting oedema          
Movements: 
     Yes     No 
Pain           
Range           
Crepitus          
 
Restriction of Movements: 
 Full restriction         
 Partial restriction       
No restriction        
Swelling of Joints: 
 Nil          
Mild          
Moderate       
Severe        
Grading of functions: 
Grade  I   Grade II  
Grade III   Grade IV   
 
SYSTEMIC EXAMINATION (EXTRA ARTICULAR FEATURES) 
   Yes             No 
Episcleritis/ scleritis  :      
Rheumatoid  Nodules :       
Peripheral Neuropathy :      
Lymphadenopathy  :      
Vasculitic Lesions  :      
Evidence of local or systemic infection :     
OTHER SYSTEM EXAMINATION: 
CVS  : 
RS  : 
Abdomen : 
RHEUMATOID ARTHRITIS DIAGNOSTIC CRITERIA 
 
1) Morning stiffness ( > 1 hr)  
   Yes        No    Never  
2) Does it last for one hour 
   Yes        No    Never  
3) Joints involved PIP – MCP – wrist – others 
More than three     Two    Less  
4) One in wrist, MCP, PIP 
                        Yes          No         
5) Joint Pain interfering with work 
Yes      No           Sometimes  
6) Bilaterally Symmetrical 
                     Yes          No   
7) Duration 
     > 6 weeks    < 6 weeks   
8) RA Nodules 
            Yes                    No  
9) RA – factor positive 
         Yes             No             Not seen  
10) C – Reactive protein 
   Yes                   No             Not seen  
11) Anti – CCP 
   Yes              No          Not seen  
12) ESR 
        Elevated               Not        elevated     
13) Joint deformity (Visible) 
   Yes                   No  
14) X – ray evidence 
   Yes             No   
15) Joint mobility restricted 
   Yes             No   
16) Muscular Atrophy 
   Yes             No   
17) Fatigue 
   Yes             No   
18) Family History 
   Yes             No   
 
Total: 
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LABORATORY INVESTIGATIONS: 
BLOOD: 
TC (Cells/cumm)  :      
DC (%)   :    P       L        E        
Hb (gms%)   :             
E.S.R. (mm/hr)  : 1/2 hr    1hr    
 
Blood Sugar(mgs%) : 
 Fasting  :  
 P.P.   :  
 Random  :  
Blood Urea   :  
Serum Bilirubin  :  
R.A. Factor  :  
C.R.P.   :              
 
URINE: 
 Albumin   :  _________   
 Sugar   :  _________  
 Deposits   :  _________     
 
MOTION TEST:             
 Ova    :  _________    
 Cyst   :  _________    
 Occult blood  :  _________ 
 
RADIOGRAPHIC EVALUATION:  
 
 
 
Discharge case sheet  Proforma for  
“UDHIRA VATHA SURONITHAM” 
P.G. POTHU MARUTHUVAM DEPARTMENT 
GOVT. SIDDHA MEDICAL COLLEGE, PALAYAMKOTTAI. 
Ward  :    Nationality  : 
I. P. No :    Religion  : 
Bed. No :    Date of Admission : 
Name  :      
Age (Years) :         Date of Discharge :  
Gender :   M F    Result   : 
Occupation :    Diagnosis  : 
Income :    Medical officer : 
Address : ……………………….. 
    ……………………….. 
    ……………………….. 
S. No. Symptoms During admission During Discharge 
1. Pain   
2. Fever   
3. Swelling   
4. Early Morning stiffness   
5. Restriction of movements   
6. Muscle wasting   
7. Deformity   
8. Rheumatoid nodules   
9. Loss of appetite   
10. Disturbed sleep   
11. Others if any   
 
Case - Sheet Proforma for 
“UDHIRA VATHA SURONITHAM” 
P.G. POTHU MARUTHUVAM DEPARTMENT 
GOVT. SIDDHA MEDICAL COLLEGE, PALAYAMKOTTAI. 
O. P. No :    Treatment starting date : 
Name  :    End of the treatment date :  
Age (Years)     :         No. of days  treated  :  
Gender :   M F    Diagnosis   : 
Occupation :    Medical officer  : 
Income :      
Address :  ……………………… 
                ……………………… 
     ……………………… 
Complaints & Duration:  
 …………………………………………………………………………………
…………………………………………………………………..………………………
…………………………………………………….. 
GENERAL EXAMINATION: 
Consciousness   : 
Nourishment   : 
Body temperature(0F)  :    
Blood pressure (mmHg) :    
Pulse rate/min   :  
Respiratory rate/min  :  
Yes   No 
Anaemia       _______________  
Jaundice       _______________ 
Cyanosis       _______________  
Clubbing       _______________ 
Pedal oedema       _______________ 
Generalised Lymphadenopathy    _______________ 
Engorged veins      _______________ 
JVP        _______________ 
IN SIDDHA ASPECTS: 
Nilam    : 
Kaalam   : 
Iym Porigal   : 
Kanmenthiriyam  : 
Mukkutram(Affected) :   
  Vatham : 
  Pitham  : 
  Kabham : 
UDAL THATHUKKAL : 
 
 
ENVAGAI THERVUGAL : 
Naa    : _______________________________ 
Niram    : _______________________________  
Mozhi    : _______________________________ 
Vizhi    : _______________________________ 
Naadi    : _______________________________ 
Sparisam   : _______________________________ 
Malam    : _______________________________ 
 
 
MOOTHIRAM  :  
 Neerkuri   
 Niram  : _______________  
  Edai  : _______________    
Manam : _______________  
  Nurai  : _______________ 
  Enjal  : _______________ 
 Nei kuri  : _______________ 
IN MODERN ASPECTS 
SYSTEMIC  EXAMINATION 
Inspection: 
Skin over the Joints : Normal   Reddish  
Joint Swelling  :  Yes    No   
 MCP, PIP : Yes    No   
 Wrist Joint : Yes    No   
 Elbow Joint : Yes    No   
 Shoulder Joint : Yes    No   
 Knee Joint : Yes    No   
 Ankle Joint : Yes    No   
 MTP Joint : Yes    No   
 Cervical Spine :  Yes    No   
Muscle Wasting : Yes    No   
 
Deformities:     Yes    No 
Swan neck deformity         
Button hole deformity        
Ulnar deviation of the fingers       
Foot deformity         
 
Palpation: 
   Present        Absent 
Local Temperature        
Tenderness           
Evidence of intra articular fluid       
Local lymphadenopathy        
Subcutaneous nodules        
  Present         Absent 
Rheumatoid vasculitis lesions      
Pitting oedema         
 
Movements: 
     Yes    No 
Pain          
Range          
Crepitus         
Restriction of Movements: 
 Full restriction         
 Partial restriction       
No restriction        
 
Swelling of Joints: 
 Nil          
Mild          
Moderate       
Severe        
 
 
 
Grading of functions: 
Grade  I   Grade II  
Grade III   Grade IV   
SYSTEMIC EXAMINATION (EXTRA ARTICULAR FEATURES) 
   Yes             No 
Episcleritis/ scleritis  :      
Rheumatoid  Nodules :       
Peripheral Neuropathy :      
Lymphadenopathy  :      
      Yes             No 
Vasculitic Lesions  :      
Evidence of local or systemic infection :     
 
OTHER SYSTEM EXAMINATION: 
CVS  : 
RS  : 
Abdomen : 
 
RHEUMATOID ARTHRITIS DIAGNOSTIC CRITERIA: 
1) Morning stiffness ( > 1 hr)  
   Yes        No    Never  
2) Does it last for one hour 
   Yes        No    Never  
3) Joints involved  PIP – MCP – wrist – others 
More than three     Two    Less  
4) One in wrist, MCP, PIP 
                        Yes          No         
5) Joint Pain interfering with work 
Yes      No           Sometimes  
 
6) Bilaterally Symmetrical 
                     Yes          No   
7) Duration 
     > 6 weeks    < 6 weeks   
8) RA Nodules 
            Yes                    No  
9)RA – factor positive 
         Yes             No             Not seen  
10) C – Reactive protein 
   Yes                   No             Not seen  
11) Anti – CCP 
   Yes              No          Not seen  
12) ESR 
        Elevated               Not        elevated     
13) Joint deformity (Visible) 
   Yes                   No  
14) X – ray evidence 
   Yes             No   
15) Joint mobility restricted 
   Yes             No   
16) Muscular Atrophy 
   Yes             No   
17) Fatigue 
   Yes             No   
18) Family History 
   Yes             No   
Total: 
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LABORATORY INVESTIGATIONS: 
BLOOD: 
TC (Cells/cumm)  :       
DC (%)   :   P      L       E     
Hb (gms%)   :             
E.S.R. (mm/hr)  : 1/2hr   1hr    
Blood Sugar(mgs%) : 
 Fasting  :  
 P.P.   :  
 Random  :  
Blood Urea   :  
Serum Bilirubin  :  
R.A. Factor  :  
C.R.P.   :              
 
URINE : 
Albumin   :  _________   
Sugar   :  _________  
Deposits   :  _________     
 
MOTION TEST :             
 Ova    :  _________    
 Cyst   :  _________    
Occult blood   :  _________ 
 
RADIOGRAPHIC EVALUATION:  
 
 
 
Origin of disease (Uthira Vatha Suronitham) 
 
Dietary Changes       Suppression of Reflexes 
Seasonal Changes  Genetic Changes  Immoral Activities 
Environmental Changes Immunological Changes  Social Factors 
 
 
Reflected on 
Soul – Mind – Body 
 
Anatomical Pathology  Patho physiology   Patho psychology 
 
Affected Ezhu   Affected tri humors Affected Trigunam 
Udal Thathukkal  
Saaram   Vatham   Sathuva gunam 
Senneer   Pitham   Rajo gunam 
Oon    Kabham   Thamo gunam 
Kozhuppu 
Enbu 
Moolai 
Sukkilam / Suronitham  
 
 
Disease 
(Diagnosed  by Envagai Thervugal)
Affected Trihumors 
 
Vatham      Pitham     Kabham 
¾Joint pain                ¾Inflammatory     ¾Erosion of bony margin 
¾Joint Swelling              Changes in joints    ¾Restriction of movements 
¾Joint stiffness               (Redness, Warmth)   ¾Changes in synovial fluid 
¾Restriction of movements 
 
Abaanan Constipation   Anal Pitham        Loss of appetite    Avalambagam        Derangement of other  
     kabha types  
Viyaanan    Restriction of    Ranjaga Pitham      Anaemia     Kilethagam       Loss of appetite 
movements  
Samaanan   Vitiation of Other  Prasaga Pitham      Pallor of skin    Santhigam               Joint swelling  
   Vayus                Restriction of movements. 
  Loss of appetite 
Kirukaran      Loss of appetite  Saathaga Pitham      Difficulty in  
              doing day to day  
               activities 
Devathathan       Sleeplessness 
 
 
Affected Ezhu Udal Thathukkal 
 
Saaram   Senneer    Oon   Kozhuppu         Enbu 
 
Loss of appetite Decrease in Udal Vanmai Muscle wasting Restriction of Movement  Joint swelling  
   (Anaemia, increased ESR, Joint swelling      Bony erosion  
   positive RA factor)          Deformity 
Diagnosis (Envagai Thervugal) 
 
Naa   Niram Mozhi         Vizhi      Malam           Moothiram             Naadi              Sparisam 
Coated tongue    Normal            Constipation                    Vatha Pitham          
Pallor of tongue                  Pitha Vatham 
  Pallor of skin (Anaemia) Pallor of Conjunctiva  Neerkuri - Normal      (Affected Joints) 
  Affected Joints- swollen  Disturbance in vision Neikuri - Snake like   Swollen  
  Warmth and redness (Cataract) in aged  Aravil Aazhi, Aazhiyil Aravu  Tender, Warmth 
 
STAGES OF PATHOGENESIS PROCESS 
       Principal  target site - Synovium - Vasculitis  (Increased vascularity, edema, congestion, villous hypertrophy)                 Other sites 
 
    Fibrinoid degeneration / necrosis (Rice bodies)                           (Cornea, Pleura, Pericardium)                 
 
    Inflammatory cell infiltration (Lymphocytes, monocytes, macrophages, plasma cells) 
 
Fibroblastic proliferation (Pallisaded histiocytes) 
 
Rheumatoid granulation  (“Pannus” invading connective tissue By creeping substitution ) 
 
Capsule and ligaments      Tendons and aponeurosis           Joints/articular cartilage   subcutaneous tissues/bursae 
 
 
              Edema      Tendon synovial sheath infiltration Pannus infiltration from synovial   Bursitis 
          Reflection into subchondral bone  
 
Laxity  Fibrosis        Pannus invasion of adjacent tendons Deprivation of nutrition  Nodules (Aschoff’s nodules) 
  
Subluxation Contractures               
 
Dislocation Severe deformities Avascularity and attrition  Cellular death  
      
     Attenuation or rupture  Fragmentation of articular cartilage or erosion of plaques  
of devitalized cartilage 
 
     Secondary deformity   Total destruction of cartilage 
    
        Ankylosis   Disorganization of joint     
 
           Secondary dislocation or juxtaarticular pathological fractures  
BT BT AF AF BS BU SC SB BS BU SC SB
P L E P L E 1/2 hr 1 hr 1/2 hr 1 hr (mg%)(mg%)(mg%)(mg%) (mg%) (mg%) (mg%) (mg%) BT AF Alb Sug Dep Ova Cyst
1 691 10400 80 18 2 10200 78 20 2 68 116 32 62 75 78 79 19 156 0.3 80 17 154 0.3 +ve +ve Nil Nil Nil Nil Nil
2 725 9900 70 20 10 9800 75 23 2 76 158 36 70 76 78 80 24 158 0.2 92 20 155 0.2 +ve +ve Nil Nil Nil Nil Nil
3 959 9100 58 38 4 9200 63 35 2 10 22 6 12 75 77 110 23 160 0.5 100 22 161 0.3 - ve - ve Nil Nil Nil Nil Nil
4 1052 9400 60 38 2 9600 73 21 6 75 125 22 50 66 70 78 20 145 0.6 86 18 155 0.5 +ve +ve Nil Nil Nil Nil Nil
5 1003 9500 56 42 2 9700 62 34 4 25 55 11 23 81 82 87 17 151 0.4 85 18 160 0.3 +ve +ve Nil Nil Nil Nil Nil
6 1284 9600 62 32 6 9800 76 19 5 62 110 24 40 64 66 110 23 160 0.4 100 20 172 0.3 +ve +ve Nil Nil Nil Nil Nil
7 2865 8800 54 44 2 9000 56 40 4 35 70 15 25 65 68 145 36 180 0.7 118 32 178 0.6 +ve +ve Nil Nil Nil Nil Nil
8 3105 8500 68 30 2 8700 66 32 2 30 66 13 20 76 78 90 17 149 0.5 96 17 162 0.5 - ve - ve Nil Nil Nil Nil Nil
9 62 10100 71 26 3 10200 68 30 2 45 82 12 26 62 64 86 24 163 0.4 94 22 172 0.4 - ve - ve Nil Nil Nil Nil Nil
10 50 10000 72 26 2 10100 75 23 2 75 130 13 22 74 76 148 37 178 0.5 118 32 182 0.4 -ve -ve Nil Nil Nil Nil Nil
11 233 7600 67 28 5 7800 60 37 3 30 65 10 18 62 64 92 14 130 0.6 86 16 156 0.5 +ve +ve Nil Nil Nil Nil Nil
12 280 9000 62 36 2 9100 64 34 2 26 43 10 16 75 76 72 15 156 0.6 80 13 158 0.5 - ve - ve Nil Nil Nil Nil Nil
13 323 9500 56 40 4 9500 60 38 2 20 42 11 18 68 71 102 31 162 0.3 112 29 160 0.3 +ve +ve Nil Nil Nil Nil Nil
14 317 10200 68 30 2 10100 70 27 3 45 92 16 28 84 86 92 19 196 0.3 98 18 192 0.3 +ve +ve Nil Nil Nil Nil Nil
15 451 9200 60 38 2 9300 63 32 5 22 53 9 15 86 87 111 19 165 0.6 116 17 162 0.6 +ve +ve Nil Nil Nil Nil Nil
16 720 9800 60 32 8 10000 66 30 4 12 25 6 11 71 74 82 23 156 0.7 90 22 158 0.6 - ve - ve Nil Nil Nil Nil Nil
17 721 9200 63 35 2 9400 62 33 5 21 44 10 20 41 46 93 31 181 0.5 98 28 178 0.4 - ve - ve Nil Nil Nil Nil Nil
18 737 9000 64 34 2 9100 69 27 4 15 22 6 11 75 76 111 26 130 0.6 104 23 140 0.6 -ve -ve Nil Nil Nil Nil Nil
19 843 8900 62 30 8 8800 70 25 5 15 25 5 9 72 74 100 23 181 0.5 96 18 178 0.4 +ve +ve Nil Nil Nil Nil Nil
20 853 9200 48 48 4 9400 54 40 6 20 40 9 16 68 70 87 26 176 0.3 92 24 177 0.3 - ve - ve Nil Nil Nil Nil Nil
AT - After Treatment                 BU - Blood Urea                                  SB - Serum Bilirubin                     APPEARANCE : Slightly turbid,  FIBRIN CLOT:  2+,  GLUCOSE DIFFERENCE - 30mg/dl, LEUCOCYTES:  11,000 cells/cumm
SI. No
Motion
AT
RA factor
                                                                                                                                                                            MUCIN CLOT:   Poor,   NEUTROPHILS: 72%.
DC%
AT
ESR (mm)AT Hb%
DC%
BT
IP. No TC CELLS/ur mm BT
(BT & AT) Urine
TC CELLS/ur mm
BT - Before Treatment              BS - Blood Sugar (Random)              SC - Serum Cholesterol                SYNOVIAL  FLUID ANALYSIS:   IP No : 50    
BT
INVESTIGATION CHART - IP CASES
BT BT AT AT BS BU SC SB BS BU SC SB
P L E P L E 1/2 hr 1 hr 1/2 hr 1 hr (mg%) (mg%) (mg%) (mg%) (mg%) (mg%) (mg%) (mg%) BT AT Alb Sug Deposits Ova Cyst
1 21349 9500 65 30 5 9600 72 26 2 17 34 8 13 74 76 79 15 149 0.4 82 13 152 0.3 - ve - ve Nil Nil Nil Nil Nil
2 20405 10000 68 30 2 10100 70 25 5 25 56 8 18 76 78 19 19 172 0.3 86 16 176 0.3 +ve +ve Nil Nil Nil Nil Nil
3 23799 6200 70 24 4 6500 73 25 2 65 110 20 32 58 63 64 15 146 0.5 73 14 150 0.4 +ve +ve Nil Nil Nil Nil Nil
4 23789 9400 56 40 4 9600 60 37 3 62 150 18 26 68 72 85 18 162 0.6 92 18 168 0.5 +ve +ve Nil Nil Nil Nil Nil
5 23880 8600 62 34 4 8800 72 24 4 70 165 23 48 62 66 72 23 176 0.4 86 21 180 0.3 +ve +ve Nil Nil Nil Nil Nil
6 24095 7300 55 42 3 7600 57 41 2 32 72 14 20 57 60 70 21 165 0.3 78 19 172 0.3 - ve - ve Nil Nil Nil Nil Nil
7 25438 9600 58 38 4 9500 52 42 6 12 35 7 13 68 70 84 18 158 0.4 92 16 164 0.4 +ve +ve Nil Nil 2 - 3 Epi. Cells Nil Nil
8 25056 8800 64 42 4 8800 68 30 2 25 56 14 23 66 70 102 20 160 0.6 96 18 172 0.6 - ve - ve Nil Nil Nil Nil Nil
9 26115 9400 58 40 2 9100 62 34 4 10 22 8 14 74 76 79 20 178 0.5 76 19 176 0.6 +ve +ve Nil Nil Nil Nil Nil
10 26512 10200 73 24 3 10100 68 28 4 26 32 11 19 75 78 82 27 152 0.4 82 26 156 0.3 - ve - ve Nil Nil Nil Nil Nil
11 26387 9900 56 42 2 9900 52 46 2 18 36 10 22 64 66 118 32 162 0.5 116 33 168 0.5 +ve +ve Nil Nil Nil Nil Nil
12 28022 9500 67 28 5 9400 65 30 5 25 52 13 24 67 70 78 26 174 0.3 82 25 178 0.3 +ve +ve Nil Nil Nil Nil Nil
13 28982 8400 56 38 6 8400 58 38 4 19 35 8 15 74 76 86 19 152 0.4 92 19 156 0.3 - ve - ve Nil Nil Nil Nil Nil
14 72832 9100 72 26 2 9200 75 22 3 15 25 7 12 76 78 162 17 226 0.6 118 16 218 0.4 +ve +ve Nil Nil Nil Nil Nil
15 73919 9800 60 30 10 9700 63 30 7 24 47 10 21 71 72 72 17 140 0.8 86 17 142 0.7 +ve +ve Nil Nil Few Pus Cells Nil Nil
16 75868 9600 66 32 2 9300 68 30 2 48 90 22 38 68 69 92 25 152 0.4 96 24 155 0.4 - ve - ve Nil Nil Nil Nil Nil
17 75815 8700 64 32 4 8800 62 35 3 21 50 12 23 64 66 78 15 156 0.7 82 15 160 0.7 +ve +ve Nil Nil Nil Nil Nil
18 319 10400 61 33 6 10200 68 28 4 20 55 9 22 74 75 87 38 186 0.4 92 18 185 0.4 +ve +ve Nil Nil Nil Nil Nil
19 3137 9900 56 41 3 9900 58 40 2 15 32 9 18 76 77 78 22 176 0.5 84 21 178 0.5 - ve - ve Nil Nil Nil Nil Nil
20 6070 9800 70 28 2 9900 72 26 2 10 20 8 16 80 81 88 33 210 0.7 92 32 208 0.7 - ve - ve Nil Nil Nil Nil Nil
INVESTIGATION CHART - OP CASES
SI. No OP. No
BT AT ESR (mm) Hb% BT AT
RA factor
     BT - Before Treatment                                                                                     BS - Blood Sugar (Random)                                                                   SC - Serum Cholesterol
     AT - After Treatment                                                                                       BU - Blood Urea                                                                                     SB - Serum Bilirubin                     
(BT & AT) Urine Motion
TC CELLS/cu. mm
DC%
TC CELLS/cu. mm
DC%
BT AT
IP OP
1 691 Kadhar Bheevi 59/F House wife 6 months 07/03/07 04/04/07 29 12 41 Good
Date of Discharge
No. of Days Treated
Total No. of days Treated Treatment with Medicine/dose Results
CASE SUMMARY OF IN-PATIENTS
S. No. Ip. No. Name Age/Sex Occupation Duration of Illness Date of Admission
2 725 Isakkiammal 45/F House wife 3 months 12/03/07 06/04/07 26 14 40 Good
3 959 Lakshmi 56/F Cook         3 years 10/04/07 19/05/07 40 0 40 Good
4 1052 Mookkammal 50/F House wife 7 months 20/04/07 11/05/07 22 28 40 Fair
5 1003 Subbaiya 72/M Farmer         1 year 21/04/07 08/05/07 19 22 41 Good
6 1284 Rani 25/F House wife 8 months 14/05/07 26/05/07 13 28 41 Good
7 2865 Annammal 65/F House wife 9 months 20/11/07 01/12/07 21 20 41 1. (Internal) Kirubagara Shanmuga Good
8 3105 Shankara vadivu 65/F Servant 5 months 24/12/07 23/01/08 31 10 41 Chenduram- 130mg (Bd) with Good
9 62 Rani 47/F House wife 8 months 09/01/08 13/02/08 36 7 43 Chukku, Milagu and Omam Good
10 50 Chandra kumari 55/F House wife         4 years 22/01/08 11/01/08 21 20 41 Choornam -1gm with Good
11 233 Latha 32/F Servant 2 months 28/01/08 11/01/08 15 7 22 Murungai Pattai Chaaru Poor
12 280 Subbammal 60/F House wife 7 months 01/02/08 18/02/08 18 7 25 Fair
13 323 Pappu 62/F House wife 9 months 02/02/08 22/02/08 21 20 41 Good
14 317 Shahul Hameed 48/M Carpenter         1 year 04/02/08 01/03/08 26 14 40 2. (External) Vathathirkku Poosa Good
15 451 Mayil vaganan 40/M Server 7 months 15/02/08 10/03/08 24 21 45 Nochi Ennei -30ml Good
16 720 Mohammed 65/M Watchman 8 months 17/03/08 31/03/08 15 14 29 Fair
17 721 Aiysha 60/F House wife 4 months 17/03/08 31/03/08 15 28 43 Good
18 737 Lakshmanan 65/M Farmer       10 months 19/03/08 04/04/08 17 14 31 Fair
19 843 Amirtha kani 45/F Beedi worker 9 months 01/04/08 24/04/08 24 21 45 Good
20 853 Petchiyammal 48/F Veg. Seller         1 month 03/04/08 28/04/08 26 14 40 Good
S. No. Ip. No. Name Age/Sex Occupation Duration of Illness
Treatment 
Started Date
Treatment 
Ended Date
Total No. of days 
treated Treatment with Medicine/dose Results
1 21349 Selvi 45/F Teacher 4 months 16/03/07 01/05/07 47 Good
2 20405 Subashree 40/F House wife 6 months 12/03/07 01/05/07 51 Good
3 23799 Sudha 27/F Beedi worker 7 months 27/03/07 07/05/07 42 Good
4 23789 Muthulakshmi 60/F House wife 9 months 27/03/07 09/05/07 44 Good
5 23880 Valli 38/F Servant Maid 5 years 28/03/07 14/05/07 48 Good
6 24095 Shanthi 45/F House wife 8 months 29/03/07 09/05/07 42 Good
7 25438 Shankaramma 48/F Servant Maid 4 years 05/04/07 16/05/07 41 1. Internal - Kirubagara Shanmuga Fair
8 25056 Kala 27/F House wife 2 months 03/04/07 13/05/07 40 Chenduram - 130mg (Bd) with Good
9 26115 Lakshmi 55/F House wife 8 months 09/04/07 19/05/07 40 Chukku, Milagu and Omam Good
10 26512 Allimeena 26/F House wife 1 month 10/04/07 21/05/07 42 Choornam - 1gm with Good
11 26387 Sautha Beevi 50/F House wife 5 months 10/04/07 21/05/07 42 Murungaipattai Chaaru Fair
12 28022 Krishnammal 39/F Cook 9 months 18/04/07 10/05/07 23 Poor
13 28982 Indhra 58/F Beedi worker 2 months 23/04/07 16/05/07 24 2. External - Vathathirkku Poosa Good
14 72832 Saraswathi 62/F House wife 4 months 10/12/07 23/01/08 43 Nochi Ennei - 30ml Good
15 73919 Ramakrishnan 60/M Dhobi 9 months 17/12/07 04/02/08 50 Good
16 75868 Muthulakshmi 50/F House wife 3 years 28/12/07 10/02/08 45 Good
17 75815 Kanagarathi 25/F Teacher 8 months 28/12/07 14/02/08 49 Good
18 319 Avudaiammal 63/F House wife 10 months 02/01/08 14/02/08 44 Good
19 3137 Kalavathi 35/F Beedi worker 3 months 09/01/08 04/02/08 27 Poor
20 6070 Abdul Raheem 81/M Shop worker 10 months 22/01/08 21/02/08 32 Good
CASE SUMMARY OF OUT-PATIENTS
Radiological Examination of OP Patients 
S. 
No 
OP 
No 
X – ray both hands 
with wrist joint, 
AP view 
X – ray knee joints 
lateral and AP view 
X – ray cervical 
spine, lateral view 
X – ray foot with 
ankle joint, oblique 
view 
1 21349 Rheumatoid arthritis  - - - 
2 20405 Osteoporosis - - - 
3 23799 Soft tissue swelling, 
poly arthritis  
- - - 
4 23789 Osteoporosis  Osteo arthritis - - 
5 23880 Rheumatoid arthritis 
with deformity 
- - - 
6 24095 Osteoporosis - Cervical 
spondylosis 
- 
7 25438 Rheumatoid arthritis 
with deformity 
- - Osteoporosis 
8 25056 Soft tissue swelling - - - 
9 26115 Poly arthritis  Osteo arthritis - - 
10 26512 Soft tissue swelling  - - - 
11 26387 Osteoporosis Osteo arthritis - - 
12 28022 Rheumatoid arthritis  - - Osteoporosis 
13 28982 Osteoporosis - Cervical 
spondylosis 
- 
14 72832 Osteoporosis  Osteo arthritis - - 
15 73919 Rheumatoid arthritis - - - 
16 75868 Osteoporosis  Osteo arthritis - - 
17 75815 Periarticular erosion - - - 
18 319 Rheumatoid arthritis  - - Osteoporosis 
19 3137 Periarticular 
osteoporosis 
- - - 
20 6070 Osteoporosis Osteo arthritis - - 
Radiological Examination of IP Patient 
S. 
No 
IP 
No 
X – ray both hands 
with wrist joint – AP 
view 
X – ray knee joints, 
lateral and AP view 
X – ray cervical 
spine, lateral view 
X – ray foot with 
ankle joint, oblique 
view 
1 691 Rheumatoid arthritis  Osteo arthritis - - 
2 725 Osteoporosis - - Osteoporosis 
3 959 Rheumatoid arthritis - - - 
4 1052 Rheumatoid arthritis  - - - 
5 1003 Osteoporosis Osteo arthritis - - 
6 1284 Soft tissue swelling  - - - 
7 2865 Rheumatoid arthritis Osteo arthritis - - 
8 3105 Osteoporosis Osteo arthritis - - 
9 62 Osteoporosis - - - 
10 50 Rheumatoid  
arthritis 
- - osteoporosis 
11 233 Soft tissue swelling - - - 
12 280 Poly arthritis Osteo arthritis - - 
13 323 Peri articular erosion  - Cervical spondylosis - 
14 317 Rheumatoid arthritis 
with deformity 
- - Osteoporosis 
15 451 Osteoporosis  - - - 
16 720 Osteoporosis - Cervical spondylosis - 
17 721 Peri articular erosion Osteo arthritis - - 
18 737 Osteoporosis  - - - 
19 843 Rheumatoid arthritis  - - Osteoporosis 
20 853 - Osteo arthritis - - 
 
 















